<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: ""
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>WO2002037077A2 - Screening methods based on transcriptional regulation analysis system using transformed cell lines 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/WO2002037077A2/en">
    <meta name="description" content="
     The present invention relates to screening methods for evaluating the activity of transcription factors or promoters using transformed cell lines. More particularly, the present invention relates to (a) screening methods for detection of substances affecting transcription activity by use of transformed cell lines, which leads to cell-based data with little artificial effects, (b) cell lines for performing the screening methods, and (c) screening methods for leading compounds for new drug. 
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Screening methods based on transcriptional regulation analysis system using transformed cell lines 
       ">
    <meta name="DC.date" content="2001-11-06" scheme="dateSubmitted">
    <meta name="DC.description" content="
     The present invention relates to screening methods for evaluating the activity of transcription factors or promoters using transformed cell lines. More particularly, the present invention relates to (a) screening methods for detection of substances affecting transcription activity by use of transformed cell lines, which leads to cell-based data with little artificial effects, (b) cell lines for performing the screening methods, and (c) screening methods for leading compounds for new drug. 
   
   ">
    <meta name="citation_patent_application_number" content="PC:T/KR2001/001881">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/50/1d/68/b4243ab1adf671/WO2002037077A2.pdf">
    <meta name="citation_patent_publication_number" content="WO:2002037077:A2">
    <meta name="DC.date" content="2002-05-10">
    <meta name="DC.contributor" content="Seok-Geun Lee" scheme="inventor">
    <meta name="DC.contributor" content="Mun-Seog Chang" scheme="inventor">
    <meta name="DC.contributor" content="Ho-Jin Shin" scheme="inventor">
    <meta name="DC.contributor" content="Hyune-Mo Rho" scheme="inventor">
    <meta name="DC.contributor" content="Medexbio Co." scheme="assignee">
    <meta name="DC.relation" content="US:5976793" scheme="references">
    <meta name="DC.relation" content="WO:1997010360:A1" scheme="references">
    <meta name="DC.relation" content="WO:1998003676:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000040720:A1" scheme="references">
    <meta name="citation_reference" content="DATABASE WPI Week 200041, Derwent Publications Ltd., London, GB; AN 2000-475830/41 &amp; WO 00 40720 A1 (SUMITOMO CHEM CO LTD) 13 July 2000" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Screening methods based on transcriptional regulation analysis system using transformed cell lines 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA69101084" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div class="abstract style-scope patent-text">The present invention relates to screening methods for evaluating the activity of transcription factors or promoters using transformed cell lines. More particularly, the present invention relates to (a) screening methods for detection of substances affecting transcription activity by use of transformed cell lines, which leads to cell-based data with little artificial effects, (b) cell lines for performing the screening methods, and (c) screening methods for leading compounds for new drug.</div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q"><a id="link" href="#" class="style-scope state-modifier">C12Q</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/00"><a id="link" href="#" class="style-scope state-modifier">C12Q1/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/68"><a id="link" href="#" class="style-scope state-modifier">C12Q1/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C12Q1/6897"><a id="link" href="#" class="style-scope state-modifier">C12Q1/6897</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/00"><a id="link" href="#" class="style-scope state-modifier">C12N15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/09"><a id="link" href="#" class="style-scope state-modifier">C12N15/09</a></state-modifier>
                  <span class="description style-scope classification-tree">Recombinant DNA-technology</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/63"><a id="link" href="#" class="style-scope state-modifier">C12N15/63</a></state-modifier>
                  <span class="description style-scope classification-tree">Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C12N15/65"><a id="link" href="#" class="style-scope state-modifier">C12N15/65</a></state-modifier>
                  <span class="description style-scope classification-tree">Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 1 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Genetics &amp; Genomics"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Genetics &amp; Genomics
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">WO2002037077A2</h2>
                  <p class="tagline style-scope patent-result">WIPO (PCT)</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">International application published without international search report</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/50/1d/68/b4243ab1adf671/WO2002037077A2.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;promoter&quot;,&quot;reporter&quot;,&quot;gene&quot;,&quot;eukaryotic&quot;,&quot;reporter vector&quot;]" data-before="20001106"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/WO2002037077A2"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002037077A2/fr"><a id="link" href="#" class="style-scope state-modifier">French</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Seok-Geun Lee"><a id="link" href="#" class="style-scope state-modifier">Seok-Geun Lee</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Mun-Seog Chang"><a id="link" href="#" class="style-scope state-modifier">Mun-Seog Chang</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Ho-Jin Shin"><a id="link" href="#" class="style-scope state-modifier">Ho-Jin Shin</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Hyune-Mo Rho"><a id="link" href="#" class="style-scope state-modifier">Hyune-Mo Rho</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2000</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR20020035393A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR1020000065656A</div>
                <div class="style-scope application-timeline">Filing date: 2000-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2001</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2002037077A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/KR2001/001881</div>
                <div class="style-scope application-timeline">Filing date: 2001-11-06</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR20030065506A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR1020037006230A</div>
                <div class="style-scope application-timeline">Filing date: 2001-11-06</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2002215239A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2002215239A</div>
                <div class="style-scope application-timeline">Filing date: 2001-11-06</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application PCT/KR2001/001881 events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2001-11-06</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Medexbio Co."><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Medexbio Co.</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="priority style-scope application-timeline">2001-11-06</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2002215239A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority to AU2002215239A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2002-05-10</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2002037077A2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of WO2002037077A2</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2002-11-07</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2002037077A3/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of WO2002037077A3</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (4)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#nplCitations" class="style-scope patent-result">Non-patent citations (1)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (9)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=WO&amp;NR=0237077A2&amp;KC=A2&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/WO/2002037077/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patentscope.wipo.int/search/en/WO2002037077">PatentScope</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/WO2002037077A2">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PDES587992" lang="EN" load-source="WIPO-OCR" class="description style-scope patent-text">
    
    <div id="p0001" num="0001" class="description-paragraph style-scope patent-text"> SCREENING METHODS BASED ON TRANSCRIPTIONAL REGULATION ANALYSIS SYSTEM USING TRANSFORMED CELL LINES</div>
    <div id="p0002" num="0002" class="description-paragraph style-scope patent-text">BACKGROUND OF THE INVENTION FIELD OF THE INVENTION</div>
    <div id="p0003" num="0003" class="description-paragraph style-scope patent-text">The present invention relates to screening methods for evaluating the activity of transcription factors or promoters using transformed cell lines. More particularly, the present invention relates to (a) screening methods for detection of substances affecting transcription activity by use of transformed cell lines, which leads to cell- based data with little artificial effects, (b) cell lines for performing the screening methods, and (c) screening methods for leading compounds for new drug.</div>
    <div id="p0004" num="0004" class="description-paragraph style-scope patent-text">DESCRIPTION OF THE RELATED ART</div>
    <div id="p0005" num="0005" class="description-paragraph style-scope patent-text">Hitherto, the investigation on the transcriptional regulation of a gene expression is generally performed in such a manner that a transcriptional regulatory region to be assayed is cloned into a locus upstream of a structural gene, which serves as reporter gene, such as luciferase and chloramphenicol acetyltransferase genes. Then, the activity of the transcriptional regulation region is measured using a transient transfection assay. The conventional method provides background informations on the regulation mechanism of the expression of many genes. Also, the conventional method has been widely used on 

biological systems by providing the valuable patterns of induction or inhibition of gene expression.</div>
    <div id="p0006" num="0006" class="description-paragraph style-scope patent-text">The transient transfection assay shows advantages such as facility and shorter time required for performing the assay; however, the assay needs many artificial handling steps relatively, which leads to artificial effects. The artificial effects render the assay unreliable. Therefore, a lot of investigators are under the study in order to overcome the foregoing shortcomings associated with the assay (see Sambrook J. et al . , Molecular Cloning: a laboratory manual , 2nd ed. , Cold Spring Harbor Laboratory Press, Cold Spring Harbo (1989) ; Villarreal, LP . and Soo, NJ., -J. Mol . Appl . Genet . , 3:62-71(1985); Seidman M. , Mutat . Res . , 220 (2-3) : 55-60 (1989) ; Howcroft TK. et al . , Anal . Biochem . , 244 : 22-27 (1997) ; Bilbao, G. et al . , FASEB J. , 11:624-634(1997); Johnson, LG. et al . , J. Virol . , 72:8861-8872(1998); Davis, RE. et al . , Proc . Natl . Acad . Sci . USA . , 96:8687-8692(1999); Yonemitsu, Y. et al . , Nat . Biotechnol . , 18:970-973(2000)). The efficiency of transfection is usually shown to be different in each experiment, depending on transfection method, a quality and an amount of DA to be introduced for transfection, and an amount of cell to be transfected, thereby giving rise to different results. Therefore, considering in vivo circumstance including cell-, tissue- and individual-level, it is necessary to develop the advanced methods . 

 In order to complement or modify the results obtained from the transient transfection method, RT-PCR or northern hybridization assay has been alternatively proposed. However, both RT-PCR and northern hybridization assay have a fatal shortcoming: the longer time is required for carrying out the assay.</div>
    <div id="p0007" num="0007" class="description-paragraph style-scope patent-text">U.S. Pat No. 5,976,793 discloses a method of transcriptionally modulating the expression of a gene-of- interest and a method of discovering chemicals capable as gene expression modulators. U.S. Pat No. 5,747,338 discloses a method and a construct for screening for inhibitors of transcriptional activators.</div>
    <div id="p0008" num="0008" class="description-paragraph style-scope patent-text">Consequently, there is a need of a novel method to overcome the shortcomings of the conventional methods, the transient transfection assay, RT-PCR and northern hybridization assay, while adopting the advantages of the conventional methods .</div>
    <div id="p0009" num="0009" class="description-paragraph style-scope patent-text">Meanwhile, advances in both genomics and combinatorial chemistry have generated an increasing number of new targets and a large number of compound libraries, which make needs for a higher rate of screening as well as an increase in the information content per screen. High- Throughput Screening (HTS) is an efficient method to discover novel and active chemical entities, so many pharmaceutical and biotechnology companies adopt this strategy for drug discovery. 

 Drug discovery and development is a process of managing failures and costs. Almost 90% of compounds for which an IND is filed fail prior to achieving an approved NDA. The cost for developing a new drug is estimated at $350-500 million and over 85% of this cost is due to the expense of preclinical and clinical trials, which means that these failures represent the majority of the cost incurred in drug discovery and development. The roles which absorption, distribution, metabolism, and excretion (ADME) play in causing these failures are significant, and one estimate found that approximately 50% of failures in preclinical and clinical trials are due to ADME deficiencies.</div>
    <div id="p0010" num="0010" class="description-paragraph style-scope patent-text">Therefore, there is a long-felt need to develop novel high throughput screening systems for measuring safety and ADME with speed and accuracy, thereby reducing dramatically the cost and the time for developing, in particular, in preclinical and clinical trials.</div>
    <div id="p0011" num="0011" class="description-paragraph style-scope patent-text">Throughout this application, various patents and publications are referenced and citations are provided in parentheses. The disclosure of these patents and publications in their entities are hereby incorporated by references into this application in order to more fully describe this invention and the state of the art to which this invention pertains. 

SUMMARY OF THE INVENTION</div>
    <div id="p0012" num="0012" class="description-paragraph style-scope patent-text">In one aspect of this invention, there is provided a method for screening substances affecting transcription activity associated with promoter, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed, in which the reporter vector carries an eukaryotic replication origin, the promoter and a reporter gene being located downstream of the promoter; and (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    <div id="p0013" num="0013" class="description-paragraph style-scope patent-text">In another aspect of this invention, there is provided a method for screening substances affecting transcription activity associated with enhancer, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed, in which the reporter vector carries an eukaryotic replication origin, a promoter, the enhancer being located upstream of the promoter and a reporter gene being located downstream of the promoter; and (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    <div id="p0014" num="0014" class="description-paragraph style-scope patent-text">In still another aspect of this invention, there is provided a method for screening substances affecting transcription activity associated with cis-element, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector 

with a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a promoter, the cis-element being located upstream of the promoter and a reporter gene being located downstream of the promoter; and (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    <div id="p0015" num="0015" class="description-paragraph style-scope patent-text">In further aspect of this invention, there is provided a method for detecting dioxin-like compounds in sample, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with the sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter lacking enhancer region, XRE being located upstream of the promoter and a reporter gene being located downstream of the promoter; and (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    <div id="p0016" num="0016" class="description-paragraph style-scope patent-text">In still further aspect of this invention, there is provided a method for screening in vivo antagonists to dioxin-like compounds, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with the dioxin-like compound and a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter lacking enhancer region, XRE being located upstream of the promoter and a reporter gene being located downstream of the promoter; and (b) measuring an activity 

or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    <div id="p0017" num="0017" class="description-paragraph style-scope patent-text">In another aspect of this invention, there is provided a TRAS-enhancer reporter vector, which comprises (a) a reporter gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter being located upstream of the reporter gene, and (f) a cloning site for receiving a transcriptional regulation sequence being a binding site of an enhancer to be analyzed, in which the cloning site is a multiple cloning site having at least 2 restriction sites and is located upstream of the eukaryotic minimal promoter. In still another aspect of this invention, there is provided a TRAS-TF reporter vector, which comprises (a) a reporter gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter being located upstream of the reporter gene, and (f) a cis-element being located upstream of the eukaryotic minimal promoter.</div>
    <div id="p0018" num="0018" class="description-paragraph style-scope patent-text">In further aspect of this invention, there is provided an eukaryotic cell line transfected stably with the vector of this invention and showing a similar growth pattern to that of cancer cell, in which the cell line is useful for the method for screening substances affecting 

transcription activity associated.</div>
    <div id="p0019" num="0019" class="description-paragraph style-scope patent-text">In still further aspect of this invention, there is provided a method for screening leading compounds of new</div>
    <div id="p0020" num="0020" class="description-paragraph style-scope patent-text"> <sub class="style-scope patent-text">*</sub> drug, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed so that the efficacy of the sample affecting transcriptional activity of target sequence is evaluated, in which the reporter vector carries an eukaryotic replication origin, a promoter and a reporter gene being located downstream of the promoter; (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector so that the sample can be evaluated in terms of pharmacological efficacy; (c) treating medium containing eukaryotic cells with the sample, in which the cell is one designed to be employed in a preliminary test prior to preclinical trials and transfected stably with a reporter vector carrying a reporter gene, and in which the preliminary test evaluates the sample in terms of one or more selected from the group consisting of a toxicity, an adverse effect associated with sex hormone, a metabolic stability and an intestinal absorption; and (d) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector of (c) . In another aspect of this invention, there is provided a method for screening leading compounds of new drug, which comprises the steps of: (a) treating medium containing 

eukaryotic cells transfected stably with a reporter vector with a sample to be assayed so that the efficacy of the sample affecting transcriptional activity of target sequence is evaluated, in which the reporter vector carries an eukaryotic replication origin, a promoter, an enhancer being located upstream of the promoter and a reporter gene being located downstream of the promoter; (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector so that the sample can be evaluated in terms of pharmacological efficacy; (c) treating medium containing eukaryotic cells with the sample, in which the cell is one designed to be employed in a preliminary test prior to preclinical trials and transfected stably with a reporter vector carrying a reporter gene, and in which the preliminary test evaluates the sample in terms of one or more selected from the group consisting of a toxicity, an adverse effect associated with sex hormone, a metabolic stability and an intestinal absorption; and (d) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector of (c) .</div>
    <div id="p0021" num="0021" class="description-paragraph style-scope patent-text">In still another aspect of this invention, there is provided a method for screening leading compounds of new drug, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed so that the efficacy of the sample affecting transcriptional activity 

of target sequence is evaluated, in which the reporter vector carries an eukaryotic replication origin, a promoter, a cis-element being located upstream of the promoter and a reporter gene being located downstream of the promoter; (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector so that the sample can be evaluated in terms of pharmacological efficacy; (c) treating medium containing eukaryotic cells with the sample, in which the cell is one designed to be employed in a preliminary test prior to preclinical trials and transfected stably with a reporter vector carrying a reporter gene, and in which the preliminary test evaluates the sample in terms of one or more selected from the group consisting of a toxicity, an adverse effect associated with sex hormone, a metabolic stability and an intestinal absorption; and (d) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector of (c) .</div>
    <div id="p0022" num="0022" class="description-paragraph style-scope patent-text">In further aspect of this invention, there is provided a method for screening leading compounds for new drug serving as in vivo antagonist to dioxin-like compounds, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with the dioxin-like compound and a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter lacking enhancer region, XRE being located upstream of the 

promoter and a reporter gene being located downstream of the promoter; (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector so that the sample can be evaluated in terms of pharmacological efficacy; (c) treating medium containing eukaryotic cells with the sample, in which the cell is one designed to be employed in a preliminary test prior to preclinical trials and transfected stably with a reporter vector carrying a reporter gene, and in which the preliminary test evaluates the sample in terms of one or more selected from the group consisting of a toxicity, an adverse effect associated with sex hormone, a metabolic stability and an intestinal absorption; and (d) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector of (c) .</div>
    <div id="p0023" num="0023" class="description-paragraph style-scope patent-text">In still further aspect of this invention, there is provided a pharmaceutical composition treating or preventing disease or disorder caused by dioxin-like compounds, in which the pharmaceutical composition is obtained from the method for screening leading compounds for new drug serving as in vivo antagonist to dioxin-like compounds .</div>
    <div id="p0024" num="0024" class="description-paragraph style-scope patent-text">Accordingly, it is an object of this invention to provide a method for screening substances affecting transcription activity.</div>
    <div id="p0025" num="0025" class="description-paragraph style-scope patent-text">It is another object of this invention to provide a 

method for detecting dioxin-like compounds in sample.</div>
    <div id="p0026" num="0026" class="description-paragraph style-scope patent-text">It is still another object of this invention to provide a method for screening in vivo antagonists to dioxin-like compounds . It is further object of this invention to provide a TRAS-enhancer reporter vector.</div>
    <div id="p0027" num="0027" class="description-paragraph style-scope patent-text">It is still further object of this invention to provide a TRAS-TF reporter vector.</div>
    <div id="p0028" num="0028" class="description-paragraph style-scope patent-text">It is another object of this invention to provide an eukaryotic cell line transfected stably with the vector of this invention.</div>
    <div id="p0029" num="0029" class="description-paragraph style-scope patent-text">It is still another object of this invention to provide a method for screening leading compounds of new drug.</div>
    <div id="p0030" num="0030" class="description-paragraph style-scope patent-text">It is further object of this invention to provide a method for screening leading compounds for new drug serving as in vivo antagonist to dioxin-like compounds.</div>
    <div id="p0031" num="0031" class="description-paragraph style-scope patent-text">It is still further object of this invention to provide a pharmaceutical composition treating or preventing disease or disorder caused by dioxin-like compounds.</div>
    <div id="p0032" num="0032" class="description-paragraph style-scope patent-text">Other objects and advantages of the present invention will become apparent from the detailed description to follow taken in conjugation with the appended claims and drawings .</div>
    <div id="p0033" num="0033" class="description-paragraph style-scope patent-text">BRIEF DESCRIPTION OF THE DRAWINGS</div>
    <div id="p0034" num="0034" class="description-paragraph style-scope patent-text">Fig. 1 is a genetic map of TRAR-Promoter-Basic vector; 

 Fig. 2 is a genetic map of TRAR-Enhancer-Basic vector; Fig. 3 is a genetic map of TRAR-XRE vector; Fig. 4 is a photograph showing PCR product demonstrating cell lines transfected with TRAS-XRE; Fig. 5 is a graph showing the activity of luciferase from cell lines transfected with TRAS-XRE;</div>
    <div id="p0035" num="0035" class="description-paragraph style-scope patent-text">Fig. 6 is a graph showing the alteration of the luciferse activity after dioxin treatment in cell lines transfected with TRAS-XRE; Fig. 7 is a graph showing the results obtained from the present method for screening antagonists to dioxin with cell lines transfected with TRAS-XRE;</div>
    <div id="p0036" num="0036" class="description-paragraph style-scope patent-text">Fig. 8 is a graph showing the possibility on quantitative analysis of substances affecting activity of transcription factor;</div>
    <div id="p0037" num="0037" class="description-paragraph style-scope patent-text">Figs. 9a and 9b are graphs representing analysis of substances affecting the activity of transcription factor to bind to NFKB response element using TRAS-NFKB HepG2 of this invention; Figs. 10a and 10b are graphs showing analysis of substances affecting the activity of transcription factor to bind to p53 response element using TRAS-p53 RE HepG2 of this invention;</div>
    <div id="p0038" num="0038" class="description-paragraph style-scope patent-text">Fig. 11 is a graph showing analysis of substances affecting the activity of promoter of SOD gene using TRAS- SOD Promoter HepG2 of this invention;</div>
    <div id="p0039" num="0039" class="description-paragraph style-scope patent-text">Fig. 12 is a graph showing the evaluation on intestinal 

absorption using TRAS-XRE Caco-2 of this invention;</div>
    <div id="p0040" num="0040" class="description-paragraph style-scope patent-text">Fig. 13 is a graph representing the results of screening of antagonist to TCDD in terms of pharmacological efficacy and toxicity according to this invention;</div>
    <div id="p0041" num="0041" class="description-paragraph style-scope patent-text">Fig. 14 is a graph representing the results of screening of antagonist to TCDD in terms of intestinal absorption; and</div>
    <div id="p0042" num="0042" class="description-paragraph style-scope patent-text">Fig. 15 is a graph showing the results of screening of antagonist to TCDD in terms of metabolic stability.</div>
    <div id="p0043" num="0043" class="description-paragraph style-scope patent-text">DETAILED DESCRIPTION OF THIS INVENTION</div>
    <div id="p0044" num="0044" class="description-paragraph style-scope patent-text">The present invention, in principle, directs to a novel system for evaluating the transcription activity in eukaryotes, which is capable of providing cell-based results with little artificial effects and obtaining the results with rapidity.</div>
    <div id="p0045" num="0045" class="description-paragraph style-scope patent-text">For the purpose of providing the novel system, we have first constructed several reporter vectors, designated as Transcriptional Regulation Analysis System (hereinafter referred to as "TRAS") .</div>
    <div id="p0046" num="0046" class="description-paragraph style-scope patent-text">According to the present methods, it is indispensable to employ eukaryotic cell lines transfected stably with the report vector designed for accomplishing the purpose of this invention. The term used herein "transfected stably" refers to that the transfected reporter vector is integrated into host chromosome and becomes a stable part of the genetic repertoire of host cell, thereby permitting 

stable expression of genes on the transfected reporter vector for at least 30 generations. Therefore, the term "cells transfected stably" has the same meaning as other analogous terms such as "stable expressing tranfectants" and "stable transfectants . "</div>
    <div id="p0047" num="0047" class="description-paragraph style-scope patent-text">Also, it is necessary for this invention that the employed eukaryotic cells be established, showing a growth pattern similar to cancer cell, that is to say, with no contact-inhibition.</div>
    <div id="p0048" num="0048" class="description-paragraph style-scope patent-text">I. Screening Methods for Detection of Substances Affecting Transcription activity Based on Transcriptional Regulation</div>
    <div id="p0049" num="0049" class="description-paragraph style-scope patent-text">Analysis System</div>
    <div id="p0050" num="0050" class="description-paragraph style-scope patent-text">The reporter gene on the vector of this invention functions as an indicator of transcription activity to be determined. The activity or the amount of the reporter protein is depended on the transcription activity controlling the expression of the reporter gene. In preferred embodiments, the reporter gene includes, but not limited to, genes encoding luciferase, chlroamphenicol acetyltransferase, -galactosidase, human growth hormone, green fluorescent protein and secreted placental alkaline phosphatase. Most preferably, the luciferase gene is used in light of facility and sensitivity of assay for activity. The methods for determining the activity of the reporters are well known to one skilled in the art: luciferase (de Wet J. et al, Mol . Cell Biol . , 7:725- 

737(1987)), chlroamphenicol acetyltransferase (Gorman C. et al, Mol . Cell Biol . , 2:1044-1051(1982)), - galactosidase (Hall C.V. et al , J<sup class="style-scope patent-text">"</sup>. Mol . Appl . Genet . , 2:101-109(1983)), human growth hormone (Selden R. et al . , Mol . Cell Biol . , 6:3173-3179(1986)), green fluorescent protein (Chalfie M. et al, Science, 263:802-805(1994)), and secreted placental alkaline phosphatase (Berger, J. et al, Gene, 66:1-10 (1988)).</div>
    <div id="p0051" num="0051" class="description-paragraph style-scope patent-text">In preferred embodiments, the eukaryotic replication origin includes, but not limited to, fl replication origin, SV40 replication origin and pMBl replicon.</div>
    <div id="p0052" num="0052" class="description-paragraph style-scope patent-text">Meanwhile, in a method for screening substances affecting transcription activity associated with promoter, non-limiting example of the promoter includes promoter of p53 gene, promoter of SOD1 gene, promoter of catalase gene and pregenome promoter of HBV (Reisman D. et al . , Proc . Natl . Acad. Sci . USA, 85:5146-5150(1988); Yoo JH. et al . , J<sup class="style-scope patent-text">"</sup>. Clin . Invest . , 93:297-302(1994); Mine E. et al . , J. Biol . Chem . , 274:503-509(1999); Chang MS. et al . , Phytother. Res . , 13:641-644(1999); and Choi BH. et al . , J<sup class="style-scope patent-text">"</sup>. Biol . Chem . , 274:2858-2865(1999)).</div>
    <div id="p0053" num="0053" class="description-paragraph style-scope patent-text">The term "promoter" inserted into TRAS vector refers to a region spanning all transcription regulatory sequences involved in transcription, which is intended to encompass broader meaning than commonly understood by one of ordinary skill in the art to which this invention belongs. 

For example, the promoter includes sequences necessary to form transcription initiation complex and other transcription regulatory sequences such as enhancer.</div>
    <div id="p0054" num="0054" class="description-paragraph style-scope patent-text">The term "enhancer" used herein has the same meaning as commonly understood by one skilled in the art.</div>
    <div id="p0055" num="0055" class="description-paragraph style-scope patent-text">By the term "cis-element" inserted into TRAS vector, it is meant a regulatory sequence unit bound to a particular transcription factor, which is capable of regulating (increasing or decreasing) transcription activity.</div>
    <div id="p0056" num="0056" class="description-paragraph style-scope patent-text">In a method for screening substances affecting transcription activity associated with enhancer or cis- element, the promoter located on the vector acts as heterologous promoter, preference of which has compact base sequence because those are respond to a specific transcription factor. The heterologous promoter includes, but not limited to, minimal promoter lacking enhancer region, SV 40 promoter and tk promoter of HSV.</div>
    <div id="p0057" num="0057" class="description-paragraph style-scope patent-text">More preferably, the promoter is the minimal promoter lacking enhancer region, for example, derived from cytomegalo virus . It is the most preferred that the minimal promoter consists of the nucleotide sequence of SEQ ID NO:l. By "minimal promoter" is meant a promoter consisting essentially of minimal sequence necessary to form a transcription initiation complex. Therefore, the minimal promoter is free of other regulatory sequences such as enhancer. 

 According to the most preferred embodiments, using the minimal promoter with no enhancer region, the level of the transcription activity of reporter gene is determined solely by the activity of enhancer or cis-element adjacent upstream of the minimal promoter. Thus, the method of this invention ensures the analysis of the sole effect of the enhancer or cis-element to be tested, while completely removing the effect of other factors affecting transcription activity. In this context, the method of this invention provides an analysis system for screening substances solely affecting transcription activity which is specifically determined by the effect of enhancer or cis-element .</div>
    <div id="p0058" num="0058" class="description-paragraph style-scope patent-text">Accordingly, in the most preferred embodiments, this invention provides a method for screening substances affecting transcription activity associated with enhancer, which comprises the steps of: (a) treating medium containing mammalian tumor cell lines transfected stably with a reporter vector with a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter derived from cytomegalo virus, the enhancer being located upstream of the minimal promoter and a luciferase gene being located downstream of the promoter; and (b) measuring an activity or a quantity of luciferase expressed.</div>
    <div id="p0059" num="0059" class="description-paragraph style-scope patent-text">In the most preferred embodiments, this invention provides a method for screening substances affecting 

transcription activity associated with cis-element, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter derived from cytomegalo virus, the cis-element being located upstream of the promoter and a luciferase gene being located downstream of the promoter; and (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    <div id="p0060" num="0060" class="description-paragraph style-scope patent-text">In a method for screening substances affecting transcription activity associated with enhancer, the enhancer includes, but not limited to SV40 enhancer, HIV Long Terminal Repeat, HBV enhancer and a individual enhancer of viral and cellualr promoters.</div>
    <div id="p0061" num="0061" class="description-paragraph style-scope patent-text">In a method for screening substances affecting transcription activity associated with cis-element, the cis-element includes NFKB (nuclear factor KB binding site) , PPRE (peroxisome proliferator response element) , HRE</div>
    <div id="p0062" num="0062" class="description-paragraph style-scope patent-text">(hydrogen peroxide response element) , MRE (metal response element) , XRE (xenobiotic response element) , PRE</div>
    <div id="p0063" num="0063" class="description-paragraph style-scope patent-text">(progesterone response element) , HSE (heat shock response element) , Spl (Spl binding site) , API (API binding site) , AP2 (AP2 binding site) and p53 (p53 binding site) , but not limited to (Zabel U. et al., J<sup class="style-scope patent-text">"</sup>. Biol . Chem . , 266:252-</div>
    <div id="p0064" num="0064" class="description-paragraph style-scope patent-text">260(1991); Jones NC. et al, Genes Dev. , 2:267-281 (1988); 

Latch an DS . Eukaryotic transcription factors . Academic Press, London; La Thangue NB. and Rigby PWJ. Trans-acting protein factors and the regulation of eukaryotic transcription . In transcription and Splicing, B. D. Hames and D. Glover (eds) , 3-42. IRL Press, Oxford.; Latchman D. Gene Regulation: A eukaryotic perspective 2nd ed. Chapman &amp; Hall, London (1995)).</div>
    <div id="p0065" num="0065" class="description-paragraph style-scope patent-text">II. Methods for Detecting Dioxin-like Compounds and for Screening in vivo Antagonists to Dioxin-like Compounds</div>
    <div id="p0066" num="0066" class="description-paragraph style-scope patent-text">These methods are practical applications in which the concept of the present invention as described above is also adopted. Therefore, the common descriptions of both I and II are abbreviated in order to avoid the complexity of this specification leading to undue multiplicity.</div>
    <div id="p0067" num="0067" class="description-paragraph style-scope patent-text">The term "Dioxin-like compounds" used herein means all compounds that belong to not only PCDD (polychlorinated dibenzodioxin) but also PCDFs (polychlorinated dibenzofurans) and PCBs (polychlorinated biphenyl family) which exhibit the same cellular effects to PCDD.</div>
    <div id="p0068" num="0068" class="description-paragraph style-scope patent-text">It is known to one skilled in the art that XRE is a transcriptional regulatory sequence bound specifically to certain receptor. The receptor is elucidated as one of mediators in signal transduction cascade triggered by endocrine disruptor such as dioxin-like compounds (FujisaWa-Sehara A. et al . , Nucleic Acids Res . , 15:4179- 

4191(1987); and Denison MS. et al . , J<sup class="style-scope patent-text">"</sup>, Biol . Chem . , 263:17221-17224 (1988) ) .</div>
    <div id="p0069" num="0069" class="description-paragraph style-scope patent-text">The XRE derived from SOD gene is employed according to the most preferable embodiment, the XRE comprises the nucleotide sequence of SEQ ID NO : 2 .</div>
    <div id="p0070" num="0070" class="description-paragraph style-scope patent-text">It is noted that the term "XRE" used herein is distinctly different from DRE (dioxin responsive element) . XRE sequence used in this invention is specific for the dioxin-Ah receptor ccomplex mediating gene expression while the DRE region includes the sequences for various binding sites of transcription factor in addition to dioxin-Ah receptor ccomplex binding site .</div>
    <div id="p0071" num="0071" class="description-paragraph style-scope patent-text">In the preferred embodiment of this invention, the XRE on the reporter vector comprises at least 2 -repeated XRE sequences, more preferably, at least 3 -repeated XRE sequences. Preferably, the repeated XRE sequences are contiguous. In fact, the contiguous XRE sequences cannot be found in nature and thus is available through artificial DA synthesis. Selection of such XRE sequences and minimal promoter is responsible for a strikingly specific analysis of transcription activity varied depending solely on the activity of XRE.</div>
    <div id="p0072" num="0072" class="description-paragraph style-scope patent-text">Michael S. Denison et al . , disclose a bioassay for detecting 2 , 3 , 7 , 8-tetrachlorodibenzo-para-dioxin and TCDD- like compounds (U.S. Pat. No. 5,854,010). The bioassay uses the DREs, which is prepared from 484 -bp fragment isolated from the 5' -flanking region of the mouse 

cytochrome P4501A1 gene.</div>
    <div id="p0073" num="0073" class="description-paragraph style-scope patent-text">However, the 484-bp fragment contains not only four DREs but also other several transcriptional regulatory sequences, as easily recognized by one skilled in the art. Further to this, the bioassay of Denison et al . employs 1330-bp MMTV fragment as promoter, which contains not only promoter but also other a variety of transcriptional regulatory sequences, also as understood by one skilled in the art . Thus, the bioassay measures the transcription activity resulted from DRE activity plus a large majority of other transcriptional regulatory sequences, which renders it unreliable. In this regard, the bioassay of Denison et al . cannot expect an accurate analysis on substances affecting DRE activity.</div>
    <div id="p0074" num="0074" class="description-paragraph style-scope patent-text">Different from the bioassay of Denison et al . , the method of this invention, in order to analyze the effect of solely XRE activity, employs the minimal promoter lacking enhancer and the synthesized XRE not containing other sequences .</div>
    <div id="p0075" num="0075" class="description-paragraph style-scope patent-text">According to the most preferable embodiment of this invention, there is provided a method for detecting dioxin-like compounds in sample, which comprises the steps of: (a) treating medium containing mammalian tumor cell lines transfected stably with a reporter vector with the sample to be assayed; in which the reporter vector carries 

an eukaryotic replication origin, a minimal promoter lacking enhancer region derived from cytomegalo virus, at least 2-repeated XRE sequences being located upstream of the promoter and a luciferase gene being located downstream of the promoter; and (b) measuring an activity or a quantity of luciferase expressed.</div>
    <div id="p0076" num="0076" class="description-paragraph style-scope patent-text">According to the most preferable embodiment, this invention provides a method for screening in vivo antagonists to dioxin-like compounds, which comprises the steps of: (a) treating medium containing mammalian tumor cell lines transfected stably with a reporter vector with the dioxin-like compound and a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter lacking enhancer region derived from cytomegalo virus, at least 2-repeated XRE sequences being located upstream of the promoter and a luciferase gene being located downstream of the promoter; and (b) measuring an activity or a quantity of luciferase expressed.</div>
    <div id="p0077" num="0077" class="description-paragraph style-scope patent-text">Ill . TRAS Vectors and Cell Lines</div>
    <div id="p0078" num="0078" class="description-paragraph style-scope patent-text">The inventors have developed vectors and cell lines for carrying out the above-described methods. As a result, the vectors and cell lines of this invention shares the concept of invention with the methods. Therefore, the common descriptions of I, II and III are abbreviated in 

order to avoid the complexity of this speci ication leading to undue multiplicity.</div>
    <div id="p0079" num="0079" class="description-paragraph style-scope patent-text">The vectors constructed by the inventors are denoted as "TRAS." TRAS is an abbreviated term for "Transcriptional Regulation Analysis System" as described above.</div>
    <div id="p0080" num="0080" class="description-paragraph style-scope patent-text">The TRAS-promoter reporter vector of this invention is designed for analysis of transcription activity associated with promoter. The TRAS-promoter reporter vector comprises</div>
    <div id="p0081" num="0081" class="description-paragraph style-scope patent-text">(a) a reporter gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, and (e) a cloning site for receiving a heterologous promoter to be analyzed, in which the cloning site has restriction site and is located upstream of the reporter gene.</div>
    <div id="p0082" num="0082" class="description-paragraph style-scope patent-text">The cloning site is preferably a multiple cloning site having at least 2 restriction sites. The multiple cloning site, for example, has a base sequence of SEQ ID NO : 3.</div>
    <div id="p0083" num="0083" class="description-paragraph style-scope patent-text">The TRAS-promoter reporter vector is exemplified by a genetic map in Fig. 1.</div>
    <div id="p0084" num="0084" class="description-paragraph style-scope patent-text">The TRAS-enhancer reporter vector of this invention is designed for preparing the TRAS-TF vector for the analysis of transcription activity associated with transcription factor binding to enhancer.</div>
    <div id="p0085" num="0085" class="description-paragraph style-scope patent-text">The TRAS-enhancer reporter vector is exemplified by a genetic map in Fig. 2. 

 The TRAS-TF reporter vector of this invention is designed for preparing the TRAS-TF vector for the analysis of transcription activity associated with transcription factor binding to enhancer.</div>
    <div id="p0086" num="0086" class="description-paragraph style-scope patent-text">The TRAS-TF vector of this invention containing XRE is exemplified by a genetic map represented by Fig. 3.</div>
    <div id="p0087" num="0087" class="description-paragraph style-scope patent-text">According to the most preferable embodiment, this invention provides a TRAS-enhancer reporter vector, which comprises (a) a luciferase gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence,</div>
    <div id="p0088" num="0088" class="description-paragraph style-scope patent-text">(d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter lacking enhancer regions derived from cytomegal virus and being located upstream of the reporter gene, and (f) a cloning site for receiving a transcriptional regulation sequence being a binding site of a transcription factor to be analyzed, in which the cloning site is a multiple cloning site having at least 2 restriction sites and is located upstream of the eukaryotic minimal promoter.</div>
    <div id="p0089" num="0089" class="description-paragraph style-scope patent-text">According to the most preferable embodiment of this invention, there is provided a TRAS-TF reporter vector, which comprises (a) a luciferase gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, 

 (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter derived from cytomegal virus and being located upstream of the reporter gene, and (f) a binding site of a eukaryotic transcription factor being located upstream of the eukaryotic promoter.</div>
    <div id="p0090" num="0090" class="description-paragraph style-scope patent-text">In the most preferred embodiment, this invention provides a TRAS-XRE reporter vector, which comprises (a) a luciferase gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter derived from cytomegal virus and being located upstream of the reporter gene, and (f) at least 2 -repeated XRE sequences being located upstream of the promoter.</div>
    <div id="p0091" num="0091" class="description-paragraph style-scope patent-text">The constructed TRAS vectors of this invention are subsequently introduced into eukaryotic cell lines for preparing assay systems of this invention described above. The host cell is generally eukaryotic cell lines, preferably animal cell lines, more preferably mammalian cell lines, most preferably human tumor cell lines such as HeLa and HepG2 cell lines. Tansfection method useful in this invention includes, but not limited to, calcium phosphate co-precipitation (Graham, F.L. et al . , Virology, 52:456(1973)), electrophoresis (Neumann, E. et al . , EMBO 

J. , 1:841(1982)) and cationic liposome (Wong, T.K. et al . , Gene, 10:87 (1980) ) .</div>
    <div id="p0092" num="0092" class="description-paragraph style-scope patent-text">The TRAS vector introduced into host cell is integrated into host chromosome through the mechanism of random recombination and becomes a stable part of the genetic repertoire of host cell . The genes contained in the vector are expressed in the same manner as genes on host chromosome . The genes originated from the vector and host are expressed upon responding to endogenous and exogenous stimulus. Thus, stably tansfected cell lines are prepared. The transfected cells with the TRAS vector are effectively selected by antibiotics resistance gene. Accordingly, by repeating selection and incubation, stably transfected cells of this invention are obtained.</div>
    <div id="p0093" num="0093" class="description-paragraph style-scope patent-text">IV. Methods for Screening Leading Compounds for New Drug The present methods for screening leading compounds for new drug aim at enhancing hit-ratio in preclinical and clinical trials, finally reducing the cost and the time required in development of a new drug.</div>
    <div id="p0094" num="0094" class="description-paragraph style-scope patent-text">The present methods can be classified into 3 types according to target sequences of measurement: (a) promoter,</div>
    <div id="p0095" num="0095" class="description-paragraph style-scope patent-text">(b) enhancer and (c) cis-element. Hence, the present methods can screen leading compounds for new drug affecting transcriptional activity associated with promoter, enhancer or cis-element.</div>
    <div id="p0096" num="0096" class="description-paragraph style-scope patent-text">In the present methods, the steps of (a) and (b) 

demonstrate directly pharmacological efficacy of samples tested and the steps (c) and (d) other important effects in view of pharmacology and pharmacokinetics, which includes safety (toxicity, adverse effect associated with sex hormone, etc.), a metabolic stability and an intestinal absorption. For increasing the hit-ratio, the present methods employ eukaryotic cells designed to measure a safty such as a toxicity and an adverse effect associated with sex hormone, a<sup class="style-scope patent-text">'</sup> metabolic stability and an intestinal absorption. The employed cells are also ones transfected stably with reporter vector which is the same as employed in step (a) of each method. The reporter vectors employed in the methods are constructed as described-above . According to preferred embodiment, the cell designed to evaluate the toxicity of the sample is one transfected stably with a reporter vector, in which the reporter vector carries an eukaryotic replication origin, a promoter, a reporter gene being located downstream of the promoter and a transcriptional regulatory sequence demonstrating a cell toxicity which is located upstream of the promoter. The transcriptional regulatory sequence demonstrating a cell toxicity includes, but not limited to, p53 RE (response element) , NFkB RE (response element) , ERE (estrogen response element) and various cytokine response elements. In the test using p53 RE, for example, up- regulation of or at least no influence on the activity of 

the response element of p53 gene can be determined to have favorable effect to cell because p53 gene is involved in anticancer activity of cell. In addition, in the test using NFkB RE, down-regulation or at least no influence on the activity of NF B response element is also determined to exhibit favorable effect to cell because NFKB is a pivotal transcription factor mediating several stresses delivered to cell, which finally induces a wide variety of physiological phenomenon. In preferred embodiment of this invention, the cell designed to evaluate a side effect associated with sex hormone of the sample is one transfected stably with a reporter vector, in which the reporter vector carries an eukaryotic replication origin, a promoter, a reporter gene being located downstream of the promoter and a transcriptional regulatory sequence demonstrating a side effect associated with sex hormone which is located upstream of the promoter, the transcriptional regulatory sequence demonstrating a side effect associated with sex hormone includes, but not limited to, estrogen RE, progesterone RE, androgen RE and various endocrine hormone RE.</div>
    <div id="p0097" num="0097" class="description-paragraph style-scope patent-text">In preferred embodiment of this invention, the cell designed to evaluate the metabolic stability of the sample expresses CytP<sub class="style-scope patent-text">4</sub>5o isomer enzymes and is one transfected stably with a reporter vector employed in step (a) of this method. Non-limiting examples of the CytP<sub class="style-scope patent-text">450</sub> isomer enzyme 

includes CYP1A1, CYP1A2, CYP2A6, CYP2C10, CYP2C19, CYP2D6, CYP2E1 and CYP3A4. More preferably, the cell used in the test of metabolic stability is NIH3T3 cell (ATCC CRL-1658) or HepG2 cell transfected stably with a reporter vector employed in step (a) of this invention.</div>
    <div id="p0098" num="0098" class="description-paragraph style-scope patent-text">In preferred embodiment of this invention, the reporter gene carried in vector includes, but not limited to, genes encoding luciferase, chlroamphenicol acetyltransferase, - galactosidase, human growth hormone, green fluorescent protein and secreted placental alkaline phosphatase. It is the most preferable to use luciferase gene.</div>
    <div id="p0099" num="0099" class="description-paragraph style-scope patent-text">In preferred embodiment, the eukaryotic replication origin includes, but not limited to, fl replication origin, SV40 replication origin and pMBl replicon. In a method for screening leading compounds for new drug affecting transcriptional activity associated with promoter, non-limiting example of the promoter includes promoter of p53 gene, promoter of SOD1 gene, promoter of catalase gene and pregenome promoter of HBV. In a method for screening leading compounds for new drug affecting transcriptional activity associated with enhancer or cis-element, the promoter, which is preferably heterologous promoter, includes the minimal promoter lacking enhancer region, SV 40 promoter and tk promoter of HSV. More preferably, the minimal promoter lacking enhancer region is derived from cytomegalo virus. It is the most preferred that the minimal promoter consists of 

the nucleotide sequence of SEQ ID NO:l.</div>
    <div id="p0100" num="0100" class="description-paragraph style-scope patent-text">In a method for screening leading compounds for new drug affecting transcriptional activity associated with enhancer, the enhancer includes, but not limited to, SV40 enhancer, HIV Long Terminal Repeat, HBV enhancer and a individual enhancer of viral and cellualr promoters.</div>
    <div id="p0101" num="0101" class="description-paragraph style-scope patent-text">In a method for screening leading compounds for new drug affecting transcriptional activity associated with cis- element, the cis-element includes NFKB binding site, PPRE, HRE, MRE, XRE, PRE, HSE, Spl binding site, API binding site, AP2 binding site and p53 binding site, but not limited to.</div>
    <div id="p0102" num="0102" class="description-paragraph style-scope patent-text">In preferred embodiment of this invention, the eukaryotic cells employed in step (a) are cells derived from mammalian tumor cell lines.</div>
    <div id="p0103" num="0103" class="description-paragraph style-scope patent-text">According to preferred embodiment, the cell designed to evaluate the intestinal absorption of the sample is one derived from human intestine or colon and transfected stably with the reporter vector employed in step (a) . More preferably, the cell designed to evaluate the intestinal absorption of the sample is Caco-2 cell (ATCC CRL-2102) or IEC-18 cell (Korean Cell Line Bank 21589) transfected stably with the reporter vector employed in step (a) of this method. In this invention, the tests to evaluate some pharmacological and pharmakinetical factors of sample may be performed in accordance with the following procedure: 

 (a) test for pharmacological efficacy; (b) test for toxicity; (c) test for metabolic stability; and (d) test for intestinal absorption. According to the specific example of this invention, the samples to be assayed are firstly evaluated as to pharmacological efficacy and then the selected samples showing significant pharmacological efficacy are evaluated as to toxicity, metabolic stability and/or intestinal absorption. Finally, the sample representing the desired results in all tests are selected in order to use as leading compounds tested in preclinical or clinical trials.</div>
    <div id="p0104" num="0104" class="description-paragraph style-scope patent-text">This method is a practical application in which the concept of the present invention as described above is also adopted. Therefore, the similar descriptions to or the same descriptions as described in I, II and III are abbreviated in order to avoid the complexity of this specification leading to undue multiplicity.</div>
    <div id="p0105" num="0105" class="description-paragraph style-scope patent-text">As describe above, the present method for screening leading compounds for new drug, provides a high throughput assay systems enabling to screen a large variety of candidates for new drug with accuracy and rapidity. It is noted that the present method raises hit-ratio of leading compounds, so that it can reduce dramatically the cost and the time required in preclinical or clinical trials. Furthermore, the present method may be employed as animal model alternatives in preclinical trials. 

 V. Method for Screening Leading Compounds for New Drug Serving as in vivo Antagonist to Dioxin-like Compounds</div>
    <div id="p0106" num="0106" class="description-paragraph style-scope patent-text">The present method is a combination of the method for screening in vivo antagonists to dioxin-like compounds described in II and the method for screening leading compounds for new drug described in IV. Therefore, the common description between them are abbreviated in order to avoid the complexity of this specification leading to undue multiplicity. It is generally recognized that the preferred or specific embodiment of this method can be fully described on the basis of the descriptions of the methods of II and IV.</div>
    <div id="p0107" num="0107" class="description-paragraph style-scope patent-text">V . Pharmaceutical Composition Treating or Preventing Disease or Disorder Caused by Dioxin-Like Compounds</div>
    <div id="p0108" num="0108" class="description-paragraph style-scope patent-text">The pharmaceutical composition of this invention is effective in treating or preventing disease or disorder caused by dioxin-like compounds. The pharmaceutical composition of this invention exhibits its pharmacological efficacy through inhibiting signal transduction in cell mediated by XRE. The diseases or disorders caused by dioxin-like compounds includes endocrine disruption, decrease of the number of sperm, decrease of weight of testis, cancer such as endometriosis, breast cancer, testis cancer and prostate cancer, malformation of sexual organ, decrease of immune function, hypospadia, etc. 

 In the pharmaceutical compositions of this invention, the active ingredient is an extract of oriental pharmaceuticals, which includes Angelica gigas Nakai ,</div>
    <div id="p0109" num="0109" class="description-paragraph style-scope patent-text">Lycii Fructus, Aurantii Immaturi Pericarpium and Aurantii Nobilis Pericarpium.</div>
    <div id="p0110" num="0110" class="description-paragraph style-scope patent-text">In the pharmaceutical compositions of this invention, the pharmaceutically acceptable carrier may be conventional one for formulation, including lactose, dextrose, sucrose, sorbitol, mannitol, starch, gum acacia, calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxy benzoate, propylhydroxy benzoate, talc, stearic acid, magnesium and mineral oil, but not limited to. The pharmaceutical compositions of this invention, further may contain wetting agent, sweetening agent, emulsifying agent, suspending agent, preservatives, flavors, perfumes, lubricating agent, or mixtures of these substances.</div>
    <div id="p0111" num="0111" class="description-paragraph style-scope patent-text">The pharmaceutical compositions of this invention, may be administered orally or parenterally.</div>
    <div id="p0112" num="0112" class="description-paragraph style-scope patent-text">The correct dosage of the pharmaceutical compositions of this invention will vary according to the particular formulation, the mode of application, age, body weight and sex of the patient, diet, time of administration, condition of the patient, drug combinations, reaction sensitivities and severity of the disease. It is understood that the ordinary skilled physician will 

readily be able to determine and prescribe a correct dosage of this pharmaceutical compositions. An exemplary daily dosage unit for human host comprises an amount of from about 0.001 mg/kg to about 100 mg/kg. According to the conventional techniques known to those skilled in the art, the pharmaceutical compositions of this invention can be formulated with pharmaceutical acceptable carrier and/or vehicle as described above, finally providing several forms including a unit dosage form. Non-limiting examples of the formulations include, but not limited to, a solution, a suspension or an emulsion, an extract, an elixir, a powder, a granule, a tablet, a capsule, a liniment, a lotion and an ointment.</div>
    <div id="p0113" num="0113" class="description-paragraph style-scope patent-text">The following specific examples are intended to be illustrative of the invention and should not be construed as limiting the scope of the invention as defined by appended claims.</div>
    <div id="p0114" num="0114" class="description-paragraph style-scope patent-text">EXAMPLE I: Construction of TRAS-Promoter-Basic Vector</div>
    <div id="p0115" num="0115" class="description-paragraph style-scope patent-text">As represented in Fig. 1, the TRAS-Promoter-Basic vector of this invention was constructed with a luciferase gene as a reporter gene and a multiple cloning site upstream of the luciferase gene. The multiple cloning site provides several insertion sites of certain transcriptional regulation sequences (e.g. promoter) for study. And the vector contains an ampicillin resistance gene for 

selection in E. coli and a neomycin resistance gene for screening human cells transfected stably with desired vector. The construction process of the TRAS-Promoter Basic vector is explained in more detail as follows: For the purpose of obtaining BGH pA, fl ori, neomycin resistance gene, ColEl and ampicillin resistance gene, pcDNA3 (Invitrogen) was digested with Bgl H (Promega) and Xfoal (Promega) . pGL3-basic vector (Promega) was cleaved with Bgl H (Promega) and Xbal (Promega) to obtain a luciferase gene. The resulting two fragments were joined to each other with T4 DNA ligase (Promega) .</div>
    <div id="p0116" num="0116" class="description-paragraph style-scope patent-text">Separately, the multiple cloning site consisting of DNA sequence represented by SEQ ID NO: 3 was designed for carrying restriction sites (Bgrlll, EcoRI , EcoRV, BstXI, Notl , Xhol , Kpnl , BamI , Clal and Nidlll ) and synthesized. Then, the synthesized multiple cloning site was introduced into between BglII and HindUl sites, and thus the vector was finally constructed, referred to as "TRAS-Promoter-Basic" .</div>
    <div id="p0117" num="0117" class="description-paragraph style-scope patent-text">EXAMPLE II: Construction of TRAS-Enhancer-Basic Vector</div>
    <div id="p0118" num="0118" class="description-paragraph style-scope patent-text">TRAS-Enhaner-Basic vector was constructed using minimal promoter lacking enhancer as heterologous promoter which is derived from CMV promoter. The construction procedure is explained in more detail as set forth hereunder: The minimal promoter (see SEQ ID O:l) was designed in such a manner that enhancer region is deleted from the immediate early promoter of hCMV (GeneBank Accession No. 

k03104) . Also, the minimal promoter was designed for containing additional BamHI and HindiII linkers at 5' and 3' ends, respectively.</div>
    <div id="p0119" num="0119" class="description-paragraph style-scope patent-text">TRAS-Promoter-Basic promoter prepared in Example I was then digested BamHI (Promega) and HindiII (Promega) and, using T4 DNA ligase (Promega) , joined to the CMV minimal promoter of the above to produce a desired vector. The resulting vector was denoted as "TRAS-Enhancer-Basic" vector.</div>
    <div id="p0120" num="0120" class="description-paragraph style-scope patent-text">Example III: Construction of TRAS-XRE</div>
    <div id="p0121" num="0121" class="description-paragraph style-scope patent-text">TRAS-XRE vector of this invention was prepared by inserting DNA sequence consisting of 5-repeated XRE into BamHI site of TRAS-Enhancer-Basic vector as follows: A 5- repeated XRE with additional BamHI and Bg-lII linkers at 5' and 3' ends thereof, respectively, was synthesized. TRAS- Enhancer-Basic vector was digested with BamHI (Promega) and, using T4 DNA ligase (Promega) , joined to the synthesized 5-repeated XRE sequence to produce a desired vector. XRE sequence used is indicated in SEQ ID:NO 2. The resulting vector was denoted as "TRAS-XRE" vector.</div>
    <div id="p0122" num="0122" class="description-paragraph style-scope patent-text">Example IV: Establishment and Confirmation of TRAS-XRE</div>
    <div id="p0123" num="0123" class="description-paragraph style-scope patent-text">Cell Line</div>
    <div id="p0124" num="0124" class="description-paragraph style-scope patent-text">IV-1: Cell Culture and Maintenance</div>
    <div id="p0125" num="0125" class="description-paragraph style-scope patent-text">All animal cell lines employed were cultured and 

maintained under 5% C0<sub class="style-scope patent-text">2</sub> atmosphere at 37C using Dulbecco ' s modified Eagle medium (DMEM; Sigma) containing penicillin (100 units/m; Gibco BRL) , streptomycin (100 /tg/m ; Gibco BRL) and 10% fetal bovine serum (Gibco BRL) . HeLa and HepG2 cell lines were purchased from American Type Culture Collection.</div>
    <div id="p0126" num="0126" class="description-paragraph style-scope patent-text">IV-2.- Transfection of Animal Cell lines</div>
    <div id="p0127" num="0127" class="description-paragraph style-scope patent-text">HeLa cells and HepG2 cells were transfected with TRAS- XRE reporter vector prepared in Example III by way of lipopectin method as follows: To 100 i of DMEM lacking serum and antibiotics, 2 i of lipopectin (Gibco BRL) was added and agitated, which was followed by incubation for 30 min. at room temperature, and then mixed with a mixture containing 100 JL of DMEM lacking serum and antibiotics and 1 g of TRAS-XRE repoter vector. Thereafter, following incubation for 30 min. at room temperature, 800 i of DMEM with no serum and antibiotics was added to adjust final volume to 1 mi, and was poured to HepG2 cells which had been already rinsed with PBS twice. Following the lapse of 6 hrs . , the medium containing HepG2 cells was replaced with a fresh DMEM containing penicillin (100 units/m; Gibco BRL) , streptomycin (100 g/vi ; Gibco BRL) and 10% fetal bovine serum (Gibco BRL) , after which was incubated for certain time period at 37C.</div>
    <div id="p0128" num="0128" class="description-paragraph style-scope patent-text">HeLa cells were transfected in the same manner as HepG2 cells above. 

IV-3 : Establishment of TRAS-XRE Cell Line</div>
    <div id="p0129" num="0129" class="description-paragraph style-scope patent-text">Following the lapse of 1 day after transfection of HeLa and HepG2 cell lines, the transfected cells were allowed to grow in DMEM containing neomycin (400 g/ml ; Gibco BRL) serving as selective medium. At 2 days after transfection, the transfected cells were divided by a ratio of 1/10 for subculturing. Thereafter, the transfected cells were allowed to grow in  the selective medium for about 20 days and individual colonies with neomycin resistance were separately allowed to grow.</div>
    <div id="p0130" num="0130" class="description-paragraph style-scope patent-text">The selected HepG2 and HeLa cell lines were denoted as "TRAS-XRE HepG2" and "TRAS-XRE HeLa", among which TRAS-XRE HepG2 cell line was deposited on October 16, 2000 in International Depository Authority, the Korean Cell Line Research Foundation and was given accession number KCLRF- BP-00034.</div>
    <div id="p0131" num="0131" class="description-paragraph style-scope patent-text">IV-4: Evaluaation on Establishment of TRAS-XRE Cell Line (1) PCR (Polymerase Chain Reaction)</div>
    <div id="p0132" num="0132" class="description-paragraph style-scope patent-text">The genome DNA of cell lines established in Example IV- 3 was isolated for template of PCR as follows: Following the harvest of the cell line established in Example IV-3, the cells washed with 0.7% NaCl twice and suspended in 10 mM Tris-HCl (pH 8.3). To the cell suspension, protease K (100 g/ ; Sigma) and 0.1% SDS were added, followed by reaction for 1 hr at 60 C and subsequent incubation for 16 

hrs at 37C. Thereafter, phenol (saturated with 1 M Tris- HCl) was added to the resultant at 1:1 v/v, agitated for 15 min. and was subject to centrifugation at 9,000 rpm. Then, the supernatant was transferred to a fresh tube, mixed with phenol/chloroform/isoamylalcohol (25 : 24 : 1) which had been already saturated with TE buffer (pH 9.0), and was centrifuged at 9,000 rpm. Again, the supernatant so obtained was transferred to a fresh tube, mixed with chloroform/isoamylalcohol (24 : 1) , and was centrifuged at 9,000 rpm. The supernatant so obtained was gently mixed with CH<sub class="style-scope patent-text">3</sub>COONa (pH 5.2, 100 mM final cone.) and 2 volumes of ethanol . Thereafter, the genome DNA was fished out with a narrow glass bar, rinsed with 80% ethanol and dried. The yielded DNA was resuspended in TE buffer and allowed to stand overnight at 4C, after which was treated with 100 g /rai of RNase A (Sigma) and incubated for 1 hr at 37<sup class="style-scope patent-text"></sup>C. Next, the resultant was mixed with phenol/chloroform/isoamylalcohol (25 :24 : 1) and was centrifuged at 9,000 rpm. Thereafter, the supernatant so obtained was transferred to a fresh tube, mixed with chloroform/isoamylalcohol (24 :1) , and was centrifuged at 9,000 rpm. The supernatant so obtained was gently mixed with CH<sub class="style-scope patent-text">3</sub>COONa (pH 5.2, 100 mM final cone.) and 2 volumes of ethanol. Thereafter, the precipitated genome DNA was fished out with a narrow glass bar, rinsed with 80% ethanol and dried. The final genome DNA so obtained was resuspended in TE buffer overnight at 4C. 

 The PCR was performed using the genome DNA obtained above as template, a set of primers, 5'-</div>
    <div id="p0133" num="0133" class="description-paragraph style-scope patent-text">CGGGAGATCTTGTGAATTCT-3' and 5' -CCGCATCCCCAGCATGCCTG-3 ' and</div>
    <div id="p0134" num="0134" class="description-paragraph style-scope patent-text">LA Taq polymerase (TaKaRa) . Sequentially, annealing for 30 sec at 55C, extension for 2 min at 72 <sup class="style-scope patent-text"></sup>C and denaturation for 30 sec at 94C were carried out for 30 cycles.</div>
    <div id="p0135" num="0135" class="description-paragraph style-scope patent-text">Thereafter, the PCR product was subject to electrophoresis on 0.8% agarose gel, demonstrating the synthesis of 2.6 kb</div>
    <div id="p0136" num="0136" class="description-paragraph style-scope patent-text">DNA comprising XRE, minimal promoter, luciferase gene and BGH pA (see Fig. 4) . Therefore, we confirmed that the established cell lines in Example IV-3 were stably transfected with TRAS-XRE.</div>
    <div id="p0137" num="0137" class="description-paragraph style-scope patent-text">(2) Expression of Luciferase Gene The assay of luciferase activity was carried out with respect to HepG2 , TRAS-XRE HepG2 , HeLa and TRAS-XRE HeLa cell lines, thereby determining expression of luciferase. First, the medium in the dish containing the above cell lines was removed, washed with lxPBS and 30 Jl of the lysis buffer (1% Triton X-100, 25 mM glycylglycine, pH 7.8 , 15 mM MgS0<sub class="style-scope patent-text">4</sub>, 4 mM EGTA and 1 mM DTT) was added, followed by incubation for 10 min at room temperature. To the tube containing 360 i of assay buffer (25 mM glycylglycine, pH 7.8, 15 mM potassium phosphate, pH 7.8 , 15 mM MgS0<sub class="style-scope patent-text">4</sub>, 4 mM EGTA, 2 mM ATP and 1 mM DTT) , 100 i of the lysed solution contained the above dish and 200 i of luciferin were added. The luminescence was finally measured on luminometer 

 (Turner Designs Instrument, TD 2020) and shown in Fig. 5.</div>
    <div id="p0138" num="0138" class="description-paragraph style-scope patent-text">Example V: Application of TRAS-XRE Cell Line</div>
    <div id="p0139" num="0139" class="description-paragraph style-scope patent-text">V-l : Determination of Activity of Transcription factors and Substances Affecting the Activity</div>
    <div id="p0140" num="0140" class="description-paragraph style-scope patent-text">TRAS-XRE HepG2 cell line established in Example IV was tested on applicability for determination of the activity of transcription factors and substances affecting the above activity as follows: 1 m of culture medium containing TRAS-XRE cell line was treated with 10 nM 2 , 3 , 7, 8-tetrachlorodibenzo-p-dioxin (TCDD; Sigma) for 24 hrs . Then, the activity of luciferase was measured in the same manner as Example IV and compared to that of the control which was not treated with TCDD. As shown in Fig. 6, the activity of luciferase in TCDD- treated group is about 7 times higher than that of the control. Such a result may be ascribed to the following signal transduction: TCDD binds to Ahr (Aryl hydrocarbon receptor) and stimulates it. TCDD-Ahr so formed binds to Arnt (Aryl hydrocarbon receptor nuclear translocator) , thereby leading to TCDD-Ahr-Arnt complex. The resulting complex, which serves as activated transcription factor, binds to XRE on TRAS-XRE, finally triggering expression of luciferase gene adjacent to XRE. As described above, TRAS-XRE cell line of this invention ensures a determination of the activity of transcription factors and a screening of substances 

affecting the above activity with no transfection and thus can avoid the uncertainty of assay results. Therefore, the cell lines of this invention enable to obtain a vast amount of data on transcription activity with rapidity and reliability.</div>
    <div id="p0141" num="0141" class="description-paragraph style-scope patent-text">V-2 : Screening of Antagonist to Substances Affecting Activity of Transcription factor TRAS-XRE cell line was evaluated about whether it is applicable to screening of antagonists to substances affecting the activity of transcription factor.</div>
    <div id="p0142" num="0142" class="description-paragraph style-scope patent-text">The medium containing TRAS-XRE HepG2 cell line was incubated with 10 nM TCDD for 24 hrs at 37<sup class="style-scope patent-text"></sup>C and then 50 i of the extract of Angelica gigas Nakai, which is used as oriental pharmaceutical for treating anemia, was added, followed by additional incubation for 24 hrs at 37C. Thereafter, the treated cells were harvested and the activity of luciferase was measured in the same manner as Example IV. Fig. 7 shows the results of this Example. As indicated in Fig. 7, the extract of Angelica gigas Nakai shows antagonistic function to in vi tro action of TCDD, which accounts for lowering the expression of luciferase gene to the level of control. Thus, it is demonstrated that the extract of Angelica gigas Nakai is an antagonistic composition capable for inhibiting the action of TCDD to XRE.</div>
    <div id="p0143" num="0143" class="description-paragraph style-scope patent-text">Consequently, TRAS-XRE cell lines of this invention 

provide high-throughput assay systems for screening antagonists to substances affecting the activity of transcription factor.</div>
    <div id="p0144" num="0144" class="description-paragraph style-scope patent-text">V-3: Quantitative Analysis of Substances Affecting Activity of Transcription factor TRAS-XRE HepG2 cell line was evaluated about whether it is applicable to quantitative analysis of substances affecting the activity of transcription factor. One ml of the medium containing TRAS-XRE HepG2 cell line was incubated with 1 pM, 10 pM, 100 pM, 1 nM and 10 nM TCDD, respectively, for 24 hrs at 37<sup class="style-scope patent-text"></sup>0 and the activity of luciferase was then measured in the same manner as Example IV. As shown in Fig. 8, the activity of luciferase measured was increased in parallel with the increase of TCDD concentration in some concentration range of TCDD. Therefore, it is understood that TRAS-XRE HepG2 of this invention gives a quantitative analysis system of screening substances affecting the activity of transcription factor.</div>
    <div id="p0145" num="0145" class="description-paragraph style-scope patent-text">Example VI: Establishment of TRAS-NFKB Cell Line and</div>
    <div id="p0146" num="0146" class="description-paragraph style-scope patent-text">Application thereof</div>
    <div id="p0147" num="0147" class="description-paragraph style-scope patent-text">VI-1: Establishment of TRAS-NFKB Cell Line</div>
    <div id="p0148" num="0148" class="description-paragraph style-scope patent-text">TRAS-NFKB was constructed in the same manner as Example 

III except for using 3-repeated NFKB RE (response element) with additional BamHI and Bgrlll linkers at 5' and 3' ends thereof instead of XRE. NFKB RE sequence used is indicated in SEQ ID NO: 4. Transfection with TRAS-NFKB into HepG2 was performed in accordance with method described in Example</div>
    <div id="p0149" num="0149" class="description-paragraph style-scope patent-text">IV and a stable transfection was confirmed using PCR.</div>
    <div id="p0150" num="0150" class="description-paragraph style-scope patent-text">VI-2: Analysis of Activity of Transcription Factor Using TRAS-NFKB Cell Line To 200 i of the medium containing TRAS-NFKB HepG2 , 3.2 ng/m, 16 ng/mft, 80 ng/m and 400 ng/m, of LPS</div>
    <div id="p0151" num="0151" class="description-paragraph style-scope patent-text">(lipopolysaccharide, Sigma), respectively, or 0.01 ng/m#,</div>
    <div id="p0152" num="0152" class="description-paragraph style-scope patent-text">0.1 ng/m, 1 ng/md, 10 ng/m and 100 ng/m of PMA (phobol myristate acetate, Sigma) , respectively, were added and incubated for 24 hrs at 37<sup class="style-scope patent-text"></sup>C and the activity of luciferase was then measured in the same manner as Example IV.</div>
    <div id="p0153" num="0153" class="description-paragraph style-scope patent-text">As demonstrated in Figs. 9a and 9b, the activity of luciferase was increased with the increase of the concentration of LPS or PMA in certain concentration range. Therefore, it is well understood that TRAS-NFKB HepG2 of this invention enables to screen substances affecting the activity of transcription factor to bind to NFKB RE, and further to provide a quantitative analysis system.</div>
    <div id="p0154" num="0154" class="description-paragraph style-scope patent-text">Example VII: Establishment of TRAS-p53 RE Cell Line and</div>
    <div id="p0155" num="0155" class="description-paragraph style-scope patent-text">Application thereof 

VII-1: Establishment of TRAS-p53 RE Cell Line</div>
    <div id="p0156" num="0156" class="description-paragraph style-scope patent-text">TRAS-p53 RE was prepared in the same manner as Example III except for using 3-repeated p53 RE (response element) with additional Bgrlll restriction sites instead of XRE. p53 RE sequence used is indicated in SEQ ID NO : 5. Transfection with TRAS-p53 RE into HepG2 was carried out according to method described in Example IV and a stable transfection was validated using PCR.</div>
    <div id="p0157" num="0157" class="description-paragraph style-scope patent-text">VII-2: Analysis of Activity of Transcription Factor Using TRAS-p53 RE Cell Line</div>
    <div id="p0158" num="0158" class="description-paragraph style-scope patent-text">To 200 i of the medium containing TRAS-p53 RE HepG2 , 3.2 ng/m, 16 ng/m, 80 ng/m and 2000 ng/mfc, of LPS, respectively, or 0.08 M, 0.4 M, 2 M and 10 M of mitomycin C (Sigma) , respectively, were added and incubated for 24 hrs at 37<sup class="style-scope patent-text"></sup>C and the activity of luciferase was then measured in the same manner as Example IV.</div>
    <div id="p0159" num="0159" class="description-paragraph style-scope patent-text">As shown in Figs. 10a and 10b, the activity of luciferase was increased with the increase of the concentration of LPS or mitomycin C in certain concentration range. Therefore, it is well understood that TRAS-p53 RE HepG2 of this invention enables to screen substances affecting the activity of transcription factor to bind to p53 RE, and further to provide a quantitative analysis system. 

 Example VIII: Establishment of TRAS-SOD Promoter Cell Line and Application thereof</div>
    <div id="p0160" num="0160" class="description-paragraph style-scope patent-text">VIII-1: Establishment of TRAS-SOD Promoter Cell Line Human Cu/Zn SOD (superoxide) promoter was obtained with PCR according to the method provided by Kim et al {Biochem . Biophys Res Commu . 201 (3) : 1526-33 (1994) ) .</div>
    <div id="p0161" num="0161" class="description-paragraph style-scope patent-text">TRAS-Promoter Basic vector constructed in Example I was digested with BamHI and Xhol , into which the human Cu/Zn SOD promoter sequence was incorporated with T4 DNA ligase, thereby constructing TRAS-SOD Promoter vecor. Then, according to method described in Example IV, HepG2 was transfected with TRAS-SOD Promoter vecor, and a stable transfection was validated through analyzing genome of Hep G2 by means of PCR.</div>
    <div id="p0162" num="0162" class="description-paragraph style-scope patent-text">VIII-2: Analysis of Activity of Promoter Using TRAS-SOD</div>
    <div id="p0163" num="0163" class="description-paragraph style-scope patent-text">Promoter Cell Line</div>
    <div id="p0164" num="0164" class="description-paragraph style-scope patent-text">To 200 i of the medium containing TRAS-SOD Promoter HepG2, was added 0.16 M, 0.8 M, 4 M and 20 M of nitric oxide (Sigma) , respectively, and incubated for 24 hrs at</div>
    <div id="p0165" num="0165" class="description-paragraph style-scope patent-text">37<sup class="style-scope patent-text"></sup>C and the activity of luciferase was then measured in the same manner as Example IV.</div>
    <div id="p0166" num="0166" class="description-paragraph style-scope patent-text">As shown in Fig. 11, the activity of luciferase was increased with the increase of the concentration of nitric acid in certain concentration range. Therefore, it is well understood that TRAS-SOD Promoter HepG2 of this invention 

enables to screen substances affecting the activity of promoter of SOD gene, and further to provide a quantitative analysis system.</div>
    <div id="p0167" num="0167" class="description-paragraph style-scope patent-text">Example IX: Establishment of Cell Line for Measuring Intestinal Absorption and Application thereof</div>
    <div id="p0168" num="0168" class="description-paragraph style-scope patent-text">IX-1: Cell Culture and Maintenance</div>
    <div id="p0169" num="0169" class="description-paragraph style-scope patent-text">The Caco-2 cell line originating from a human colorectal carcinoma was obtained from the American Type Culture Collection. Caco-2 cells were grown in 75-cm<sup class="style-scope patent-text">2</sup> T- flasks in a 5% C0<sub class="style-scope patent-text">2</sub>/95% air atmosphere at 37<sup class="style-scope patent-text"></sup>C. The culture medium was Eagle's minimum essential medium (Sigma) with Earle ' s salts, 20% FBS, 1% nonessential amino acids, 100 units/m^, penicillin, and 0.1 mg/ml streptomycin. Cells were passaged weekly at a split ratio of 1:5 at 80% confluency, using trypsin-EDTA.</div>
    <div id="p0170" num="0170" class="description-paragraph style-scope patent-text">IX-2: Establishment of TRAS-XRE Caco-2 Cell Line Caco-2 cells in Example IX-1 were seeded in 96-well microplate (2.0 x 10<sup class="style-scope patent-text">4</sup> cells per well) and grown overnight.</div>
    <div id="p0171" num="0171" class="description-paragraph style-scope patent-text">Then, according to method described in Example IV, Caco-2 cells were transfected with TRAS-XRE and a stable transfection was validated through analyzing genome of Caco-2 cells by means of PCR. In TRAS-XRE Caco-2 cells,</div>
    <div id="p0172" num="0172" class="description-paragraph style-scope patent-text">XRE sequences used are 1 set, 2 sets and 3 sets of 5- repeated XREs, respectively. 

IX-3: Measurement of Intestinal Absorption Using TRAS-XRE Caco-2 Cell</div>
    <div id="p0173" num="0173" class="description-paragraph style-scope patent-text">To 200 i of the medium containing TRAS-XRE Caco-2 cell, was added 1 pM, 10 pM, 100 pM 1 nM and 10 nM of TCDD, respectively, and incubated for 12 hrs at 37<sup class="style-scope patent-text"></sup>C and the activity of luciferase was then measured in the same way as Example IV.</div>
    <div id="p0174" num="0174" class="description-paragraph style-scope patent-text">As shown in Fig. 12, the activity of luciferase was increased with the increase of the concentration of TCDD, i.e., TCDD exhibits intestinal absorption. Therefore,</div>
    <div id="p0175" num="0175" class="description-paragraph style-scope patent-text">TRAS-XRE Caco-2 of this invention enables measurement of intestinal absorption of certain substances.</div>
    <div id="p0176" num="0176" class="description-paragraph style-scope patent-text">Example X: Screening of Antagonist to TCDD Using Multiple</div>
    <div id="p0177" num="0177" class="description-paragraph style-scope patent-text">Cell Lines-Based Screening System</div>
    <div id="p0178" num="0178" class="description-paragraph style-scope patent-text">X-l : Screening in terms of Pharmacological Efficacy</div>
    <div id="p0179" num="0179" class="description-paragraph style-scope patent-text">To about 1 g of each of oriental pharmaceuticals (100 types) purchased in Gyeongdong Market (Korea) , was added 4 ml of tertiary DW and distillation was performed for 30 min. at 121 <sup class="style-scope patent-text"></sup>C . The distillate was centrifuged at 4000 x g and room temperature and the supernatant was then taken in order to use it as candidates of antagonist to TCDD. 0.2 ml of the medium containing TRAS-XRE constructed was treated with 1 nM TCDD for 24 hrs at 37<sup class="style-scope patent-text"></sup>C and 5 i of each of the resultant extracts was added, followed by additional 

incubation for 24 hrs at 37<sup class="style-scope patent-text"></sup>C. Thereafter, the treated cells were harvested and the activity of luciferase was measured in the same manner as described in Example IV.</div>
    <div id="p0180" num="0180" class="description-paragraph style-scope patent-text">X-2: Screening in terms of Toxicity</div>
    <div id="p0181" num="0181" class="description-paragraph style-scope patent-text">To 0.2 ml of the medium containing TRAS-NFKB HepG2 established in Example VI, was added 1 nM TCDD for 24 hrs at 37<sup class="style-scope patent-text"></sup>C and 5 i of each of the extracts from the oriental pharmaceuticals, followed by additional incubation for 24 hrs at 37<sup class="style-scope patent-text"></sup>C. Thereafter, the treated cells were harvested and the activity of luciferase was measured in the same manner as described in Example IV.</div>
    <div id="p0182" num="0182" class="description-paragraph style-scope patent-text">In addition, the same experiment was performed with TRAS-p53 RE HepG2 instead of TRAS-NFKB HepG2. Up-regulation of or at least no influence on the activity of the response element of p53 gene is determined to have favorable effect to cell because p53 gene is involved in anticancer activity of cell.</div>
    <div id="p0183" num="0183" class="description-paragraph style-scope patent-text">In addition, down-regulation or at least no influence on the activity of NFKB response element is also determined to exhibit favorable effect to cell since NFKB is a pivotal transcription factor mediating several stresses delivered to cell, which finally induces a wide variety of physiological phenomenon. Therefore, the results obtained in this Example elucidate adequately a toxicity of the sample to be tested. 

 Fig. 13 represents the results from Examples X-l and X- 2. In Fig. 13, the most leftward bar shows the negative control and</div>
    <div id="p0184" num="0184" class="description-paragraph style-scope patent-text">Based on the results derived from Examples X-l and X-2, the inventors could select several candidates satisfying the following criteria: (a) lowering dramatically the increased activity of luciferase by TCDD, i.e., exhibiting antagonistic activity to TCDD; (b) showing no activity, at least positive influence with respect to p53 RE; and (c) showing no activity, at least negative influence with respect to NFKB RE.</div>
    <div id="p0185" num="0185" class="description-paragraph style-scope patent-text">As known in Fig. 13, the extracts from oriental pharmaceuticals numbered 3, 7, 11, 15, 18, 27, 31, 33, 48, 61, 77, 84, 87 and 100 satisfy the above-described criteria.</div>
    <div id="p0186" num="0186" class="description-paragraph style-scope patent-text">X-3 : Screening in terms of Intestinal Absorption</div>
    <div id="p0187" num="0187" class="description-paragraph style-scope patent-text">The candidates selected in Examples X-l and X-2 in terms of pharmacological efficacy and toxicity, were evaluated in terms of intestinal absorption.</div>
    <div id="p0188" num="0188" class="description-paragraph style-scope patent-text">To 0.2 ml of the medium containing TRAS-XRE Caco-2 cells established in Example IX, was added 1 nM TCDD for</div>
    <div id="p0189" num="0189" class="description-paragraph style-scope patent-text">24 hrs at 37 <sup class="style-scope patent-text"></sup>C and 5 l of each of the candidates selected in Examples X-l and X-2, followed by additional incubation for 24 hrs at 37<sup class="style-scope patent-text"></sup>C . Thereafter, the treated cells were harvested and the activity of luciferase was measured in the same manner as described in Example IV. 

 As demonstrated in Fig. 14, it is known that, among the candidates selected in Examples X-l and X-2, the candidates numbered 7, 11, 15, 18, 27, 33, 84, 97 and 100 represent a remarkable intestinal absorption.</div>
    <div id="p0190" num="0190" class="description-paragraph style-scope patent-text">X-4 : Screening in terms of Metabolic Stability</div>
    <div id="p0191" num="0191" class="description-paragraph style-scope patent-text">TRAS-XRE HepG2 in Example IV was employed as cell line for measuring metabolic stability. HepG2 cells derived from human hepatocellular carcinoma cells express cytochrome P450 isomer enzymes such as CYPIAI, CYP1A2 , CYP2A6, CYP2C10, CYP2C19, CYP2D6, CYP2E1 and CYP3A4 which are responsible for metabolism and detoxification of drugs and chemicals in blood (Barouki R, Morel Y. Biochem . Pharmacol . , 61:511-6(2001); Le Marchand et al . , Cancer Res . 58:4858-4863(1998); and Sen A, Arinc E. Comp . Biochem. Physiol . C Toxicol . Pharmacol . 126:235-244(2000)).</div>
    <div id="p0192" num="0192" class="description-paragraph style-scope patent-text">To 0.2 ml of the medium containing TRAS-XRE HepG2 in Example IV, was added 1 nM TCDD for 24 hrs at 37<sup class="style-scope patent-text"></sup>C and 5 i of each of the candidates selected in Examples X-l and X-2, followed by additional incubation for 72 hrs at 37C. Thereafter, the treated cells were harvested and the activity of luciferase was measured in the same manner as described in Example IV. The treatment period with the candidates was prolonged, so that the extent of metabolic degradation of active ingredients in the candidates may fully evaluated.</div>
    <div id="p0193" num="0193" class="description-paragraph style-scope patent-text">Fig. 15 represents a marked metabolic stability of the 

candidates numbered 3, 11, 15, 18, 27, 31, 48, 77 and 100.</div>
    <div id="p0194" num="0194" class="description-paragraph style-scope patent-text">With the results from Examples X-3 and X-4, among the candidates selected in terms of pharmacological efficacy and toxicity, the candidates numbered 11, 15, 18, 27 and</div>
    <div id="p0195" num="0195" class="description-paragraph style-scope patent-text">100 exhibit both significant intestinal absorption and metabolic stability.</div>
    <div id="p0196" num="0196" class="description-paragraph style-scope patent-text">From 100 types of oriental pharmaceuticals, it is finally determined that the extracts from 5 types are excellent candidates of antagonist to TCDD in terms of pharmacology and pharmacokinetics . Namely, the extracts from 5 types finally selected show an appreciable pharmacological efficacy and little toxicity as well as significant intestinal absorption and metabolic stability. The candidates finally selected are the extracts derived from: (a) Angelica gigas Nakai , (b) Lycii Fructus, (c) Aurantii I maturi Pericarpium, (d) Aurantii Nobilis Pericarpium and (e) Chrysanthemi Flos .</div>
    <div id="p0197" num="0197" class="description-paragraph style-scope patent-text">Example XI : Preclinical Trial</div>
    <div id="p0198" num="0198" class="description-paragraph style-scope patent-text">The preclinical trial was performed using rat with respect to the candidates selected in Example X as follows:</div>
    <div id="p0199" num="0199" class="description-paragraph style-scope patent-text">Male Guinea Pig rats aged 5 weeks, purchased from BioKorea Co . , were employed as experimental animal . The 

 treatment groups with each of the candidates consist of 6 rats, respectively. One ^/kg of TCDD was once administered to rat in intraperitoneal route at initial day of experiment or at 7 days after experiment. The extracts from oriental pharmaceuticals were orally administered at a dose of 0.03-0.3 g/day/kg for 28 days from initial day of experiment. After breeding, each of the test rats was examined for its body weight, then were anesthetized with ethyl ether and sacrificed, after which testes weight was measured. The results are shown in Tables 1-5. Table 1. Results for Extract from Angelica gigas Nakai</div>
    <div id="p0200" num="0200" class="description-paragraph style-scope patent-text">
      <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c6/0c/d8/4224cb13117c9f/imgf000055_0001.png" class="style-scope patent-text"><img id="imgf000055_0001" he="137" wi="155" file="imgf000055_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="yes" width="620" height="548" alt="Figure imgf000055_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c6/0c/d8/4224cb13117c9f/imgf000055_0001.png"></a></div>
    </div>
    <div id="p0201" num="0201" class="description-paragraph style-scope patent-text">1) the extract was administered 7 days after TCDD 

 treatment .</div>
    <div id="p0202" num="0202" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">2)</sup> TCDD was administered 7 days after initiation of experiment .</div>
    <div id="p0203" num="0203" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">3)</sup> testes weight relative to body weight of rat tested (100 g) .</div>
    <div id="p0204" num="0204" class="description-paragraph style-scope patent-text">Table 2. Results for Extract f om Lycii Fructus</div>
    <div id="p0205" num="0205" class="description-paragraph style-scope patent-text">
      <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7c/6e/a9/441d06f6dfa808/imgf000056_0001.png" class="style-scope patent-text"><img id="imgf000056_0001" he="137" wi="156" file="imgf000056_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="yes" width="624" height="548" alt="Figure imgf000056_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7c/6e/a9/441d06f6dfa808/imgf000056_0001.png"></a></div>
    </div>
    <div id="p0206" num="0206" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">1)</sup> the extract was administered 7 days after TCDD treatment .</div>
    <div id="p0207" num="0207" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">2)</sup> TCDD was administered 7 days after initiation of experiment .</div>
    <div id="p0208" num="0208" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">3)</sup> testes weight relative to body weight of rat tested (100 g) . 

 Table 3. Results for Extract from Aurantii Immaturi Peri carpi urn</div>
    <div id="p0209" num="0209" class="description-paragraph style-scope patent-text">
      <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5f/77/2f/618d48a304ca6b/imgf000057_0001.png" class="style-scope patent-text"><img id="imgf000057_0001" he="138" wi="156" file="imgf000057_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="yes" width="624" height="552" alt="Figure imgf000057_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5f/77/2f/618d48a304ca6b/imgf000057_0001.png"></a></div>
    </div>
    <div id="p0210" num="0210" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">1)</sup> the extract was administered 7 days after TCDD treatment .</div>
    <div id="p0211" num="0211" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">2)</sup> TCDD was administered 7 days after initiation of experiment .</div>
    <div id="p0212" num="0212" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">3&gt;</sup> testes weight relative to body weight of rat tested (100 g) . 

 Table 4. Results for Extract from Aurantii Nobilis Pericarpium</div>
    <div id="p0213" num="0213" class="description-paragraph style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/20/44/58/019ae45a9ece97/imgf000058_0001.png" class="style-scope patent-text"><img id="imgf000058_0001" he="137" wi="155" file="imgf000058_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="yes" width="620" height="548" alt="Figure imgf000058_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/20/44/58/019ae45a9ece97/imgf000058_0001.png"></a></div>
 the extract was administered 7 days after TCDD treatment .</div>
    <div id="p0214" num="0214" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">2)</sup> TCDD was administered 7 days after initiation of experiment .</div>
    <div id="p0215" num="0215" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">3)</sup> testes weight relative to body weight of rat tested (100 g) . 
</div>
    <div id="p0216" num="0216" class="description-paragraph style-scope patent-text">
      <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4e/4f/a3/88ca935752626b/imgf000059_0001.png" class="style-scope patent-text"><img id="imgf000059_0001" he="142" wi="155" file="imgf000059_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="yes" width="620" height="568" alt="Figure imgf000059_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4e/4f/a3/88ca935752626b/imgf000059_0001.png"></a></div>
    </div>
    <div id="p0217" num="0217" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">1)</sup> the extract was administered 7 days after TCDD treatment .</div>
    <div id="p0218" num="0218" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">2)</sup> TCDD was administered 7 days after initiation of experiment .</div>
    <div id="p0219" num="0219" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">3)</sup> testes weight relative to body weight of rat tested (100 g) .</div>
    <div id="p0220" num="0220" class="description-paragraph style-scope patent-text">As described in Table 1, the extract derived from Angelica gigas Nakai , prevents and treats both the loss of body weight and the loss of testes weight of rats treated with TCDD. It is elucidated that the extract from Angelica 

gigas Nakai can serve as antagonist to TCDD.</div>
    <div id="p0221" num="0221" class="description-paragraph style-scope patent-text">In addition, the extract derived from Lycii Fructus prevents and treats both the loss of body weight and the loss of testes weight of rats treated with TCDD, which is indicated in Table 2. It is understood that the extract derived from Lycii Fructus can act as antagonist to TCDD.</div>
    <div id="p0222" num="0222" class="description-paragraph style-scope patent-text">Tables 3 and 4 also show the antagonistic action to TCDD of extracts derived from Aurantii Immaturi Pericarpium and Aurantii Nobilis Pericarpium, respectively. In contrast, the extract derived from Chrysanthemi Flos may has little or no antagonistic activity to TCDD, which is demonstrated in Table 5. It is noted that in vi tro test using multiple cell lines-based screening system of this invention, the extract derived from Chrysanthemi Flos is elucidated to exert antagonistic action to TCDD.</div>
    <div id="p0223" num="0223" class="description-paragraph style-scope patent-text">Consequently, among 5 types of the candidates selected in multiple cell lines-based screening system of this invention, which were revealed to function as antagonist to TCDD in transcriptional level, 4 types exhibit antagonistic action to TCDD in vivo test with rat model: (a) Angelica gigas Nakai , (b) Lycii Fructus, (c) Aurantii Immaturi Pericarpium, and (d) Aurantii Nobilis Pericarpium . Surprisingly, the candidates selected with the multiple cell lines-based screening system of this invention show 80% of hit-ratio in preclinical trial.</div>
    <div id="p0224" num="0224" class="description-paragraph style-scope patent-text">Having described a preferred embodiment of the present 

invention, it is to be understood that variants and modifications thereof falling within the spirit of the invention may become apparent to those skilled in this art, and the scope of this invention is to be determined by appended claims and their equivalents . 

</div>
    <div id="p0225" num="0225" class="description-paragraph style-scope patent-text">BUDAPEST TREATY ON THE INTEU<sup class="style-scope patent-text">'</sup>.ATIONAI-.</div>
    <div id="p0226" num="0226" class="description-paragraph style-scope patent-text">RECOGNITION OF THE DEPOSIT 01' MIC ROORGNKSMS</div>
    <div id="p0227" num="0227" class="description-paragraph style-scope patent-text">FOR THE PURPOSE OF PATENT PROCED HRE</div>
    <div id="p0228" num="0228" class="description-paragraph style-scope patent-text">INTERNATIONAL FORM</div>
    <div id="p0229" num="0229" class="description-paragraph style-scope patent-text">RECEPTION IN THE CASE OF AN ORIGINAL DEPOSIT issued pursuant to Rule 7.1 o: e exbio Co.</div>
    <div id="p0230" num="0230" class="description-paragraph style-scope patent-text">Seoul National University, San 56-1, Shillim-dong</div>
    <div id="p0231" num="0231" class="description-paragraph style-scope patent-text">Kanak-gu, Seoul, 151-742, KOREA</div>
    <div id="p0232" num="0232" class="description-paragraph style-scope patent-text">IDENTIFICATION OF THE MICROORGANISM</div>
    <div id="p0233" num="0233" class="description-paragraph style-scope patent-text">Accession number given by the</div>
    <div id="p0234" num="0234" class="description-paragraph style-scope patent-text">Identification reference given by the INTERNATIONAL DEPOSITARY- AUTHORITY: DEPOSITOR : TRAS-XRE HepG2</div>
    <div id="p0235" num="0235" class="description-paragraph style-scope patent-text">KCLRF-BP-00034</div>
    <div id="p0236" num="0236" class="description-paragraph style-scope patent-text">II. SCIENTIFIC DESCRIPTION AND/OR PROPOSED TAXONOMlC DESIGNATION</div>
    <div id="p0237" num="0237" class="description-paragraph style-scope patent-text">The microorganism identified under 1 above was accompanied by</div>
    <div id="p0238" num="0238" class="description-paragraph style-scope patent-text">A scientific description</div>
    <div id="p0239" num="0239" class="description-paragraph style-scope patent-text">A proposed taxonomic designation</div>
    <div id="p0240" num="0240" class="description-paragraph style-scope patent-text">(Mark with a cross where applicable)</div>
    <div id="p0241" num="0241" class="description-paragraph style-scope patent-text">HI. RECEIPT AND ACCEPTANCE</div>
    <div id="p0242" num="0242" class="description-paragraph style-scope patent-text">This International Depositary Authority accepts the microorganism identified under I ab.e, which was received by it on October 16, 2001)</div>
    <div id="p0243" num="0243" class="description-paragraph style-scope patent-text">IV. INTERNATIONAL DEPOSITARY AUTHORITY</div>
    <div id="p0244" num="0244" class="description-paragraph style-scope patent-text">Name : Director</div>
    <div id="p0245" num="0245" class="description-paragraph style-scope patent-text">Korean Cell Line Research Signati. re(s) Foil nd lion &lt;r V"2-' <sup class="style-scope patent-text"></sup>fi -</div>
    <div id="p0246" num="0246" class="description-paragraph style-scope patent-text">Address : Cancer Research Institute Date : 2000. 10. 30 Seoul National University College of Medicine 28 Yongon-dong, Cliongiio-Gu Seoul, II 0-744, orea I n HP/-I (KCI.I.F Form 17) P.ii-i- iU' 
</div>
  </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result" hidden="">()</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PCLM598294" lang="EN" load-source="WIPO-OCR" class="claims ocr style-scope patent-text">
    <claim-statement class="style-scope patent-text">What is claimed is:</claim-statement>
    <claim id="clm-0001" num="1" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">1. A method for screening substances affecting transcription activity associated with promoter, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed, in which the reporter vector carries an eukaryotic replication origin, the promoter and a reporter gene being located downstream of the promoter; and</div>
      <div class="claim-text style-scope patent-text">(b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    </claim>
    <claim id="clm-0002" num="2" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">2. A method for screening substances affecting transcription activity associated with enhancer, which comprises the steps of :</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed, in which the reporter vector carries an eukaryotic replication origin, a promoter, the enhancer being located upstream of the promoter and a reporter gene being located downstream of the promoter; and</div>
      <div class="claim-text style-scope patent-text">(b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    </claim>
    <claim id="clm-0003" num="3" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">3. A method for screening substances affecting  transcription activity associated with cis-element, which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a promoter, the cis-element being located upstream of the promoter and a reporter gene being located downstream of the promoter; and (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    </claim>
    <claim id="clm-0004" num="4" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">4. The method according to any one of claims 1 to 3 , wherein the reporter gene is one selected from the group consisting of genes encoding luciferase, chlroamphenicol acetyltransferase, -galactosidase, human growth hormone, green fluorescent protein and secreted placental alkaline phosphatase .</div>
    </claim>
    <claim id="clm-0005" num="5" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">5. The method according to claim 4, wherein the reporter gene is luciferase.</div>
    </claim>
    <claim id="clm-0006" num="6" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">6. The method according to any one of claims 1 to 3 , wherein the eukaryotic replication origin is one selected from the group consisting of fl replication origin, SV40 replication origin and p Bl replicon.  </div>
    </claim>
    <claim id="clm-0007" num="7" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">7. The method according to claim 1, wherein the promoter is one selected from the group consisting of promoter of p53 gene, promoter of SOD1 gene, promoter of catalase gene and pregenome promoter of HBV.</div>
    </claim>
    <claim id="clm-0008" num="8" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">8. The method according to claims 2 or 3 , wherein the promoter is one selected from the group consisting of minimal promoter lacking enhancer region, SV 40 promoter and tk promoter of HSV.</div>
    </claim>
    <claim id="clm-0009" num="9" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">9. The method according to claim 8, wherein the minimal promoter lacking enhancer region is derived from cytomegalo virus .</div>
    </claim>
    <claim id="clm-0010" num="10" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">10. The method according to claim 9, wherein the minimal promoter consists of the nucleotide sequence of SEQ ID NO:l.</div>
    </claim>
    <claim id="clm-0011" num="11" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">11. The method according to claim 3, wherein the cis- element is one selected from the group consisting of NFKB,</div>
      <div class="claim-text style-scope patent-text">PP E, HRE, MRE, XRE, PRE, HSE, Spl, API, AP2 and p53.</div>
    </claim>
    <claim id="clm-0012" num="12" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">12. The method according to any one of claims 1 to 3 , wherein the eukaryotic cells are cells derived from mammalian tumor cell lines.</div>
    </claim>
    <claim id="clm-0013" num="13" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">13. A method for screening substances affecting  transcription activity associated with enhancer, which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing mammalian tumor cell lines transfected stably with a reporter vector with a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter derived from cytomegalo virus, the enhancer being located upstream of the minimal promoter and a luciferase gene being located downstream of the promoter; and</div>
      <div class="claim-text style-scope patent-text">(b) measuring an activity or a quantity of luciferase expressed.</div>
    </claim>
    <claim id="clm-0014" num="14" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">14. A method for screening substances affecting transcription activity associated with cis-element, which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter derived from cytomegalo virus, the cis- element being located upstream of the promoter and a luciferase gene being located downstream of the promoter; and (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.  </div>
    </claim>
    <claim id="clm-0015" num="15" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">15. A method for detecting dioxin-like compounds in sample, which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing eukaryotic cells transfected stably with a reporter vector with the sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter lacking enhancer region, XRE being located upstream of the promoter and a reporter gene being located downstream of the promoter; and (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    </claim>
    <claim id="clm-0016" num="16" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">16. A method for screening in vivo antagonists to dioxin- like compounds, which comprises the steps of: (a) treating medium containing eukaryotic cells transfected stably with a reporter vector with the dioxin-like compound and a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter lacking enhancer region, XRE being located upstream of the promoter and a reporter gene being located downstream of the promoter; and</div>
      <div class="claim-text style-scope patent-text">(b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector.</div>
    </claim>
    <claim id="clm-0017" num="17" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">17. The method according to claims 15 or 16, wherein the reporter gene is one selected from the group consisting of  genes encoding luciferase, chlroamphenicol acetyltransferase, -galactosidase, human growth hormone, green fluorescent protein and secreted placental alkaline phosphatasereporter.</div>
    </claim>
    <claim id="clm-0018" num="18" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">18. The method according to claim 17, the reporter gene is a gene encoding luciferase.</div>
    </claim>
    <claim id="clm-0019" num="19" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">19. The method according to claims 15 or 16, wherein the XRE is derived from SOD gene.</div>
    </claim>
    <claim id="clm-0020" num="20" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">20. The method according to claim 19, wherein the XRE comprises the nucleotide sequence of SEQ ID NO : 2.</div>
    </claim>
    <claim id="clm-0021" num="21" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">21. The method according to claim 20, wherein the XRE comprises at least 2-repeated XRE sequences.</div>
    </claim>
    <claim id="clm-0022" num="22" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">22. The method according to claim 21, wherein the repeated XRE sequences are contiguous.</div>
    </claim>
    <claim id="clm-0023" num="23" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">23. The method according to claims 16 or 17, wherein the minimal promoter is derived from cytomegalo virus.</div>
    </claim>
    <claim id="clm-0024" num="24" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">24. The method according to claim 20, wherein the minimal promoter consists of the nucleotide sequence of SEQ ID</div>
      <div class="claim-text style-scope patent-text">NO:l.  </div>
    </claim>
    <claim id="clm-0025" num="25" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">25. The method according to claims 15 or 16, wherein the eukaryotic cells are mammalian tumor cell lines.</div>
    </claim>
    <claim id="clm-0026" num="26" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">26. A method for detecting dioxin-like compounds in sample, which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing mammalian tumor cell lines transfected stably with a reporter vector with the sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter lacking enhancer region derived from cytomegalo virus, at least 2 -repeated XRE sequences being located upstream of the promoter and a luciferase gene being located downstream of the promoter; and</div>
      <div class="claim-text style-scope patent-text">(b) measuring an activity or a quantity of luciferase expressed.</div>
    </claim>
    <claim id="clm-0027" num="27" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">27. A method for screening in vivo antagonists to dioxin- like compounds, which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing mammalian tumor cell lines transfected stably with a reporter vector with the dioxin-like compound and a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter lacking enhancer region derived from cytomegalo virus, at least 2- repeated XRE sequences being located upstream of the promoter and a luciferase gene being located downstream of the promoter; and  (b) measuring an activity or a quantity of luciferase expressed.</div>
    </claim>
    <claim id="clm-0028" num="28" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">28. A TRAS-enhancer reporter vector, which comprises (a) a reporter gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter being located upstream of the reporter gene, and (f) a cloning site for receiving a transcriptional regulation sequence being a binding site of an enhancer to be analyzed, in which the cloning site is a multiple cloning site having at least 2 restriction sites and is located upstream of the eukaryotic minimal promoter.</div>
    </claim>
    <claim id="clm-0029" num="29" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">29. A TRAS-TF reporter vector, which comprises (a) a reporter gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter being located upstream of the reporter gene, and (f) a cis-element being located upstream of the eukaryotic minimal promoter.</div>
    </claim>
    <claim id="clm-0030" num="30" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">30. The vector according to claims 28 or 29, wherein the reporter gene is one selected from the group consisting of genes encoding luciferase, chlroamphenicol acetyltransferase, -galactosidase, human growth hormone,  green fluorescent protein and secreted placental alkaline phosphatase; the eukaryotic replication origin is one selected from the group consisting of fl replication origin, SV40 replication origin and pMBl replicon.</div>
    </claim>
    <claim id="clm-0031" num="31" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">31. The vector according to claim 30, wherein the reporter gene is a gene encoding luciferase.</div>
    </claim>
    <claim id="clm-0032" num="32" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">32. The vector according to claims 28 or 29, wherein the eukaryotic minimal promoter lacks enhancer regions and is derived from cytomegalo virus .</div>
    </claim>
    <claim id="clm-0033" num="33" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">33. The vector according to claim 32, wherein the eukaryotic minimal promoter consists of the nucleotide sequence of SEQ ID NO:l.</div>
    </claim>
    <claim id="clm-0034" num="34" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">34. The vector according to claim 28, wherein the vector has a genetic map represented by Fig. 2.</div>
    </claim>
    <claim id="clm-0035" num="35" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">35. The vector according to claim 29, wherein the cis- element is one selected from the group consisting of NFKB binding site, peroxisome response element, hydrogen peroxide response element, metal response element, XRE, progesterone response element, heat shock response element, Spl binding site, API binding site, AP2 binding site and p53 binding site.  </div>
    </claim>
    <claim id="clm-0036" num="36" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">36. The TRAS-TF reporter vector according to claim 35, wherein the cis-element is XRE.</div>
    </claim>
    <claim id="clm-0037" num="37" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">37. The TRAS-TF reporter vector according to claim 36, wherein the vector has a genetic map represented by Fig. 3.</div>
    </claim>
    <claim id="clm-0038" num="38" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">38. A TRAS-enhancer reporter vector, which comprises (a) a luciferase gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter lacking enhancer regions derived from cytomegal virus and being located upstream of the reporter gene, and (f) a cloning site for receiving a transcriptional regulation sequence being a binding site of a transcription factor to be analyzed, in which the cloning site is a multiple cloning site having at least 2 restriction sites and is located upstream of the eukaryotic minimal promoter.</div>
    </claim>
    <claim id="clm-0039" num="39" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">39. A TRAS-TF reporter vector, which comprises (a) a luciferase gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter derived from cytomegal virus and being located upstream of the reporter gene, and (f) a cis-element being located upstream of the eukaryotic promoter.  </div>
    </claim>
    <claim id="clm-0040" num="40" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">40. A TRAS-XRE reporter vector, which comprises (a) a luciferase gene, (b) an eukaryotic replication origin, (c) a polyadenylation signal sequence, (d) a gene for resistance to antibiotics affecting eukaryotic cells as selection marker, (e) an eukaryotic minimal promoter derived from cytomegal virus and being located upstream of the reporter gene, and (f) at least 2 -repeated XRE sequences being located upstream of the promoter.</div>
    </claim>
    <claim id="clm-0041" num="41" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">41. An eukaryotic cell line transfected stably with the vector of claim 39 and showing a similar growth pattern to that of cancer cell, in which the cell line is useful in the method according to claim 3.</div>
    </claim>
    <claim id="clm-0042" num="42" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">42. An eukaryotic cell line transfected stably with the vector of claim 40 and showing a similar growing pattern to that of cancer cell, in which the cell line is useful in the method according claims 15 or 16.</div>
    </claim>
    <claim id="clm-0043" num="43" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">43. The cell line according to claims 41 or 42, wherein the cell line is mammalian tumor cell line.</div>
    </claim>
    <claim id="clm-0044" num="44" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">44. The eukaryotic cell line according to claim 43, wherein the eukaryotic cell line is TRAS-XRE HepG2 (KCLRF- BP-00034) .  </div>
    </claim>
    <claim id="clm-0045" num="45" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">45. A method for screening leading compounds of new drug, which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed so that the efficacy of the sample affecting transcriptional activity of target sequence is evaluated, in which the reporter vector carries an eukaryotic replication origin, a promoter and a reporter gene being located downstream of the promoter; (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector so that the sample can be evaluated in terms of pharmacological efficacy;</div>
      <div class="claim-text style-scope patent-text">(c) treating medium containing eukaryotic cells with the sample, in which the cell is one designed to be employed in a preliminary test prior to preclinical trials and transfected stably with a reporter vector carrying a reporter gene, and in which the preliminary test evaluates the sample in terms of one or more selected from the group consisting of a toxicity, an adverse effect associated with sex hormone, a metabolic stability and an intestinal absorption; and</div>
      <div class="claim-text style-scope patent-text">(d) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector of (c) .</div>
    </claim>
    <claim id="clm-0046" num="46" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">46. A method for screening leading compounds of new drug,  which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed so that the efficacy of the sample affecting transcriptional activity of target sequence is evaluated, in which the reporter vector carries an eukaryotic replication origin, a promoter, an enhancer being located upstream of the promoter and a reporter gene being located downstream of the promoter; (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector so that the sample can be evaluated in terms of pharmacological efficacy;</div>
      <div class="claim-text style-scope patent-text">(c) treating medium containing eukaryotic cells with the sample, in which the cell is one designed to be employed in a preliminary test prior to preclinical trials and transfected stably with a reporter vector carrying a reporter gene, and in which the preliminary test evaluates the sample in terms of one or more selected from the group consisting of a toxicity, an adverse effect associated with sex hormone, a metabolic stability and an intestinal absorption; and</div>
      <div class="claim-text style-scope patent-text">(d) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector of (c) .</div>
    </claim>
    <claim id="clm-0047" num="47" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">47. A method for screening leading compounds of new drug,  which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing eukaryotic cells transfected stably with a reporter vector with a sample to be assayed so that the efficacy of the sample affecting transcriptional activity of target sequence is evaluated, in which the reporter vector carries an eukaryotic replication origin, a promoter, a cis- element being located upstream of the promoter and a reporter gene being located downstream of the promoter; (b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector so that the sample can be evaluated in terms of pharmacological efficacy;</div>
      <div class="claim-text style-scope patent-text">(c) treating medium containing eukaryotic cells with the sample, in which the cell is one designed to be employed in a preliminary test prior to preclinical trials and transfected stably with a reporter vector carrying a reporter gene, and in which the preliminary test evaluates the sample in terms of one or more selected from the group consisting of a toxicity, an adverse effect associated with sex hormone, a metabolic stability and an intestinal absorption; and</div>
      <div class="claim-text style-scope patent-text">(d) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector of (c) .</div>
    </claim>
    <claim id="clm-0048" num="48" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">48. The method according to any one of claims 46 to 48,  wherein the cell designed to evaluate the toxicity of the sample is one transfected stably with a reporter vector, in which the reporter vector carries an eukaryotic replication origin, a promoter, a reporter gene being located downstream of the promoter and a transcriptional regulatory sequence demonstrating a cell toxicity which is located upstream of the promoter.</div>
    </claim>
    <claim id="clm-0049" num="49" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">49. The method according to claim 48, wherein the transcriptional regulatory sequence demonstrating a cell toxicity is selected from the group consisting of p53 RE, NFkB RE, estrogen RE and cytokine RE.</div>
    </claim>
    <claim id="clm-0050" num="50" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">50. The method according to any one of claims 45 to 47, wherein the cell designed to evaluate a side effect associated with sex hormone of the sample is one transfected stably with a reporter vector, in which the reporter vector carries an eukaryotic replication origin, a promoter, a reporter gene being located downstream of the promoter and a transcriptional regulatory sequence demonstrating a side effect associated with sex hormone which is located upstream of the promoter.</div>
    </claim>
    <claim id="clm-0051" num="51" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">51. The method according claim 50, wherein the transcriptional regulatory sequence demonstrating a side effect associated with sex hormone is selected from the estrogen RE, progesterone RE, androgen RE and endocrine  hormone RE .</div>
    </claim>
    <claim id="clm-0052" num="52" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">52. The method according to any one of claims 45 to 47, wherein the cell designed to evaluate the intestinal absorption of the sample is one derived from human intestine or colon and transfected stably with the reporter vector employed in step (a) of any one of claims 45 to 47.</div>
    </claim>
    <claim id="clm-0053" num="53" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">53. The method according to claim 52, wherein the cell designed to evaluate the intestinal absorption of the sample is Caco-2 cell or IEC-18 cell transfected stably with the reporter vector employed in step (a) of any one of claims 45 to 47.</div>
    </claim>
    <claim id="clm-0054" num="54" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">54. The method according to any one of claims 45 to 47, wherein the cell designed to evaluate the metabolic stability of the sample expresses CytP<sub class="style-scope patent-text">45</sub>o isomer enzymes and is one transfected stably with a reporter vector employed in step (a) of any one of claims 45 to 47.</div>
    </claim>
    <claim id="clm-0055" num="55" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">55. The method according to claim 54, wherein the CytP<sub class="style-scope patent-text">50</sub> isomer enzyme is selected from the group consisting of CYPIAI, CYP1A2, CYP2A6 , CYP2C10, CYP2C19, CYP2D6, CYP2E1 and CYP3A4.</div>
    </claim>
    <claim id="clm-0056" num="56" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">56. The method according to claim 55, wherein the cell is  NIH3T3 cell or HepG2 cell transfected stably with a reporter vector employed in step (a) of any one of claims 45 to 47.</div>
    </claim>
    <claim id="clm-0057" num="57" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">57. The method according to any one of claims 45 to 47, wherein the reporter gene is one selected from the group consisting of genes encoding luciferase, chlroamphenicol acetyltransferase, -galactosidase, human growth hormone, green fluorescent protein and secreted placental alkaline phosphatase .</div>
    </claim>
    <claim id="clm-0058" num="58" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">58. The method according to claim 58, wherein the reporter gene is luciferase.</div>
    </claim>
    <claim id="clm-0059" num="59" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">59. The method according to any one of claims 45 to 47, wherein the eukaryotic replication origin is one selected from the group consisting of fl replication origin, SV40 replication origin and pMBl replicon.</div>
    </claim>
    <claim id="clm-0060" num="60" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">60. The method according to claim 45, wherein the promoter is one selected from the group consisting of promoter of p53 gene, promoter of SOD1 gene, promoter of catalase gene and pregenome promoter of HBV.</div>
    </claim>
    <claim id="clm-0061" num="61" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">61. The method according to claims 46 or 47, wherein the promoter is one selected from the group consisting of minimal promoter lacking enhancer region, SV 40 promoter  and tk promoter of HSV.</div>
    </claim>
    <claim id="clm-0062" num="62" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">62. The method according to claim 61, wherein the minimal promoter lacking enhancer region is derived from cytomegalo virus .</div>
    </claim>
    <claim id="clm-0063" num="63" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">63. The method according to claim 62, wherein the minimal promoter consists of the nucleotide sequence of SEQ ID NO:l.</div>
    </claim>
    <claim id="clm-0064" num="64" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">64. The method according to claim 47, wherein the cis- element is one selected from the group consisting of NFKB binding site, peroxisome response element, hydrogen peroxide response element, metal response element, XRE, progesterone response element, heat shock response element, Spl binding site, API binding site, AP2 binding site and p53 binding site.</div>
    </claim>
    <claim id="clm-0065" num="65" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">65. The method according to any one of claims 45 to 47, wherein the eukaryotic cells employed in step (a) are cells derived from mammalian tumor cell lines.</div>
    </claim>
    <claim id="clm-0066" num="66" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">66. A method for screening leading compounds for new drug serving as in vivo antagonist to dioxin-like compounds, which comprises the steps of:</div>
      <div class="claim-text style-scope patent-text">(a) treating medium containing eukaryotic cells transfected stably with a reporter vector with the  dioxin-like compound and a sample to be assayed; in which the reporter vector carries an eukaryotic replication origin, a minimal promoter lacking enhancer region, XRE being located upstream of the promoter and a reporter gene being located downstream of the promoter;</div>
      <div class="claim-text style-scope patent-text">(b) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector so that the sample can be evaluated in terms of pharmacological efficacy;</div>
      <div class="claim-text style-scope patent-text">(c) treating medium containing eukaryotic cells with the sample, in which the cell is one designed to be employed in a preliminary test prior to preclinical trials and transfected stably with a reporter vector carrying a reporter gene, and in which the preliminary test evaluates the sample in terms of one or more selected from the group consisting of a toxicity, an adverse effect associated with sex hormone, a metabolic stability and an intestinal absorption; and (d) measuring an activity or a quantity of protein encoded by the reporter gene on the reporter vector of (c) .</div>
    </claim>
    <claim id="clm-0067" num="67" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">67. The method according to claim 66, wherein the cell designed to evaluate the toxicity of the sample is one transfected stably with a reporter vector, in which the reporter vector carries an eukaryotic replication origin,  a promoter, a reporter gene being located downstream of the promoter and a transcriptional regulatory sequence demonstrating a cell toxicity which is located upstream of the promoter.</div>
    </claim>
    <claim id="clm-0068" num="68" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">68. The method according to claim 67, wherein the transcriptional regulatory sequence demonstrating a cell toxicity is selected from the group consisting of p53 RE, NFkB RE, estrogen RE and cytokine RE.</div>
    </claim>
    <claim id="clm-0069" num="69" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">69. The method according to claim 66, wherein the cell designed to evaluate a side effect associated with sex hormone of the sample is one transfected stably with a reporter vector, in which the reporter vector carries an eukaryotic replication origin, a promoter, a reporter gene being located downstream of the promoter and a transcriptional regulatory sequence demonstrating a side effect associated with sex hormone which is located upstream of the promoter.</div>
    </claim>
    <claim id="clm-0070" num="70" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">70. The method according claim 69, wherein the transcriptional regulatory sequence demonstrating a side effect associated with sex hormone is selected from the estrogen RE, progesterone RE, androgen RE and endocrine hormone RE .</div>
    </claim>
    <claim id="clm-0071" num="71" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">71. The method according to claim 66 , wherein the cell  designed to evaluate the intestinal absorption of the sample is one derived from human intestine or colon and transfected stably with the reporter vector employed in step (a) .</div>
    </claim>
    <claim id="clm-0072" num="72" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">72. The method according to claim 71, wherein the cell designed to evaluate the intestinal absorption of the sample is Caco-2 cell or IEC-18 cell transfected stably with the reporter vector employed in step (a) .</div>
    </claim>
    <claim id="clm-0073" num="73" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">73. The method according to claim 66, wherein the cell designed to evaluate the metabolic stability of the sample expresses CytP<sub class="style-scope patent-text">450</sub> isomer enzymes and is one transfected stably with a reporter vector employed in step (a) .</div>
    </claim>
    <claim id="clm-0074" num="74" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">74. The method according to claim 73, wherein the CytP<sub class="style-scope patent-text">450</sub> isomer enzyme is selected from the group consisting of CYPIAI, CYP1A2, CYP2A6 , CYP2C10, CYP2C19, CYP2D6, CYP2E1 and CYP3A4.</div>
    </claim>
    <claim id="clm-0075" num="75" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">75. The method according to claim 74, wherein the cell is NIH3T3 cell or HepG2 cell transfected stably with a reporter vector employed in step (a) .</div>
    </claim>
    <claim id="clm-0076" num="76" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">76. The method according to claim 66, wherein the reporter gene is one selected from the group consisting of genes encoding luciferase, chlroamphenicol acetyltransferase, -  galactosidase, human growth hormone, green fluorescent protein and secreted placental alkaline phosphatase reporter.</div>
    </claim>
    <claim id="clm-0077" num="77" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">77. The method according to claim 76, the reporter gene is a gene encoding luciferase.</div>
    </claim>
    <claim id="clm-0078" num="78" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">78. The method according to claim 76, wherein the XRE is derived from SOD gene .</div>
    </claim>
    <claim id="clm-0079" num="79" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">79. The method according to claim 78, wherein the XRE comprises the nucleotide sequence of SEQ ID NO : 2.</div>
    </claim>
    <claim id="clm-0080" num="80" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">80. The method according to claim 79, wherein the XRE comprises at least 2 -repeated XRE sequences.</div>
    </claim>
    <claim id="clm-0081" num="81" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">81. The method according to claim 80, wherein the repeated XRE sequences are contiguous.</div>
    </claim>
    <claim id="clm-0082" num="82" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">82. The method according to claim 66, wherein the minimal promoter is derived from cytomegalo virus.</div>
    </claim>
    <claim id="clm-0083" num="83" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">83. The method according to claim 82, wherein the minimal promoter consists of the nucleotide sequence of SEQ ID NO : 1.</div>
    </claim>
    <claim id="clm-0084" num="84" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">84. The method according to claim 66 , wherein the  eukaryotic cells in step (a) are mammalian tumor cell lines .</div>
    </claim>
    <claim id="clm-0085" num="85" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">85. A pharmaceutical composition treating or preventing disease or disorder caused by dioxin-like compounds, in which the pharmaceutical composition is obtained from the method according to any one of claims 66-84.</div>
    </claim>
    <claim id="clm-0086" num="86" class="style-scope patent-text">
      <div class="claim-text style-scope patent-text">86. The pharmaceutical composition according to claim 85, wherein the pharmaceutical composition comprises (a) a pharmaceutically effective amount of an extract of one or more selected from the group consisting of Angelica gigas Nakai , Lycii Fructus, Aurantii Immaturi Pericarpium and Aurantii Nobilis Pericarpium; and (b) a pharmaceutically acceptable carrier. </div>
    </claim>
  </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (4)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1997010360A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1997010360A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-09-13</span>
                    <span class="td style-scope patent-result">1997-03-20</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">Method and construct for screening for inhibitors of transcriptional activation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1998003676A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1998003676A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-07-17</span>
                    <span class="td style-scope patent-result">1998-01-29</span>
                    <span class="td style-scope patent-result">Hagenmaier Hans Paul</span>
                    <span class="td style-scope patent-result">Process for detecting effectors of intra- and/or intercellular protein-protein interactions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5976793A/en"><a id="link" href="#" class="style-scope state-modifier">US5976793A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-07-18</span>
                    <span class="td style-scope patent-result">1999-11-02</span>
                    <span class="td style-scope patent-result">Oncogene Science, Inc.</span>
                    <span class="td style-scope patent-result">Methods of transcriptionally modulating gene expression and of discovering chemicals capable as gene expression modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000040720A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000040720A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-01-08</span>
                    <span class="td style-scope patent-result">2000-07-13</span>
                    <span class="td style-scope patent-result">Sumitomo Chemical Company, Limited</span>
                    <span class="td style-scope patent-result">Cells for measuring ability to promote transcription 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="nplCitations" class="scroll-target style-scope patent-result">
              Non-Patent Citations (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      DATABASE WPI Week 200041, Derwent Publications Ltd., London, GB; AN 2000-475830/41 &amp; WO 00 40720 A1 (SUMITOMO CHEM CO LTD) 13 July 2000
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (9)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN103305550A/en"><a id="link" href="#" class="style-scope state-modifier">CN103305550A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-04-10</span>
                    <span class="td style-scope patent-result">2013-09-18</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Reporter gene carrier for detecting activity of AP2alpha transcription factor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110257430A/en"><a id="link" href="#" class="style-scope state-modifier">CN110257430A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-06-19</span>
                    <span class="td style-scope patent-result">2019-09-20</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">A kind of active enhancer screening vector and its construction method 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110885845A/en"><a id="link" href="#" class="style-scope state-modifier">CN110885845A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-06-19</span>
                    <span class="td style-scope patent-result">2020-03-17</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Method for screening active enhancer by using vector based on random sequence 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10987362B2/en"><a id="link" href="#" class="style-scope state-modifier">US10987362B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-12</span>
                    <span class="td style-scope patent-result">2021-04-27</span>
                    <span class="td style-scope patent-result">Intercept Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Treatment of fibrosis using FXR ligands 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN116286991A/en"><a id="link" href="#" class="style-scope state-modifier">CN116286991A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-02-10</span>
                    <span class="td style-scope patent-result">2023-06-23</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Whole genome enhancer screening system, screening method and application 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR100711939B1/en"><a id="link" href="#" class="style-scope state-modifier">KR100711939B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-12-29</span>
                    <span class="td style-scope patent-result">2007-05-02</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Screening method using transformant and recombinant virus 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR100783491B1/en"><a id="link" href="#" class="style-scope state-modifier">KR100783491B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-07-27</span>
                    <span class="td style-scope patent-result">2007-12-07</span>
                    <span class="td style-scope patent-result"> </span>
                    <span class="td style-scope patent-result">Vector for evaluating the activity of promoter evaluating method using the same and promoter isolated by the method 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101144885B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101144885B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-09</span>
                    <span class="td style-scope patent-result">2012-06-13</span>
                    <span class="td style-scope patent-result"> </span>
                    <span class="td style-scope patent-result">Dual biosensor for detecting estrogen, dioxin, and derivatives thereof and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101428566B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101428566B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-09</span>
                    <span class="td style-scope patent-result">2014-08-11</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Recombinant fluorescent translational reporter vector for detecting promoter strength or expression level of target protein and uses thereof 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party,  Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/1188026240503333181"><a id="link" href="#" class="style-scope state-modifier">Westendorp et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994</span>
                    <span class="td style-scope patent-result">Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/4444278907307821794"><a id="link" href="#" class="style-scope state-modifier">Lai et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999</span>
                    <span class="td style-scope patent-result">Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/5554715472940020022"><a id="link" href="#" class="style-scope state-modifier">Cunningham et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991</span>
                    <span class="td style-scope patent-result">Expression of the DAL80 gene, whose product is homologous to the GATA factors and is a negative regulator of multiple nitrogen catabolic genes in Saccharomyces cerevisiae, is sensitive to nitrogen catabolite repression</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/3538962557441975154"><a id="link" href="#" class="style-scope state-modifier">Lin et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999</span>
                    <span class="td style-scope patent-result">Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/10540454710591884715"><a id="link" href="#" class="style-scope state-modifier">Flemington et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990</span>
                    <span class="td style-scope patent-result">Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/13647542621024439030"><a id="link" href="#" class="style-scope state-modifier">Vogan et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996</span>
                    <span class="td style-scope patent-result">An alternative splicing event in the Pax-3 paired domain identifies the linker region as a key determinant of paired domain DNA-binding activity</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/2208247183837045016"><a id="link" href="#" class="style-scope state-modifier">Bull et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990</span>
                    <span class="td style-scope patent-result">The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/9663924071272078932"><a id="link" href="#" class="style-scope state-modifier">Lloyd et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991</span>
                    <span class="td style-scope patent-result">Transformation suppressor activity of a Jun transcription factor lacking its activation domain</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/6732461239890806964"><a id="link" href="#" class="style-scope state-modifier">Haugen et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988</span>
                    <span class="td style-scope patent-result">Sequencespecific and general transcriptional activation by the bovine papillomavirus1 E2 transactivator require an Nterminal amphipathic helixcontaining E2 domain.</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/240149993708697025"><a id="link" href="#" class="style-scope state-modifier">De Gregorio et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999</span>
                    <span class="td style-scope patent-result">Translation driven by an eIF4G core domain in vivo</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/12697692409021520650"><a id="link" href="#" class="style-scope state-modifier">Pastorcic et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986</span>
                    <span class="td style-scope patent-result">Control of transcription initiation in vitro requires binding of a transcription factor to the distal promoter of the ovalbumin gene</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/15325558941208645518"><a id="link" href="#" class="style-scope state-modifier">Haluska Jr et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999</span>
                    <span class="td style-scope patent-result">Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/5087462147493256842"><a id="link" href="#" class="style-scope state-modifier">Gorgoni et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005</span>
                    <span class="td style-scope patent-result">The stemloop binding protein stimulates histone translation at an early step in the initiation pathway</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/7945963658615077293"><a id="link" href="#" class="style-scope state-modifier">Kyo et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993</span>
                    <span class="td style-scope patent-result">NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002037077A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002037077A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-10</span>
                    <span class="td style-scope patent-result">Screening methods based on transcriptional regulation analysis system using transformed cell lines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/11356464039847802213"><a id="link" href="#" class="style-scope state-modifier">Rothofsky et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997</span>
                    <span class="td style-scope patent-result">CROC-1 encodes a protein which mediates transcriptional activation of the human FOS promoter</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/7234802626512787619"><a id="link" href="#" class="style-scope state-modifier">Marden et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003</span>
                    <span class="td style-scope patent-result">Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/5483037653810602356"><a id="link" href="#" class="style-scope state-modifier">Dikstein et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990</span>
                    <span class="td style-scope patent-result">Hierarchic and cooperative binding of the rat liver nuclear protein C/EBP at the hepatitis B virus enhancer</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/9094976398507205031"><a id="link" href="#" class="style-scope state-modifier">Lu et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005</span>
                    <span class="td style-scope patent-result">Interleukin-12 p40 promoter activity is regulated by the reversible acetylation mediated by HDAC1 and p300</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/15214000055265106245"><a id="link" href="#" class="style-scope state-modifier">Houglum et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994</span>
                    <span class="td style-scope patent-result">LAP (NF-IL6) transactivates the collagen alpha 1 (I) gene from a 5'regulatory region.</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/343900590750461824"><a id="link" href="#" class="style-scope state-modifier">Stamataki et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001</span>
                    <span class="td style-scope patent-result">Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/17644124075787190932"><a id="link" href="#" class="style-scope state-modifier">Kuprash et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996</span>
                    <span class="td style-scope patent-result">Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation.</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE69935414T2/en"><a id="link" href="#" class="style-scope state-modifier">DE69935414T2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-15</span>
                    <span class="td style-scope patent-result">
  Human h-TRCP protein
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/15594158327371459110"><a id="link" href="#" class="style-scope state-modifier">O'Donnell et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002</span>
                    <span class="td style-scope patent-result">The proximal promoter region is essential for lipopolysaccharide induction and cyclic AMP inhibition of mouse tumor necrosis factor-</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/9170299572367158281"><a id="link" href="#" class="style-scope state-modifier">Illenye et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004</span>
                    <span class="td style-scope patent-result">Functional analysis of bacterial artificial chromosomes in mammalian cells: mouse Cdc6 is associated with the mitotic spindle apparatus</span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="applicationPriorityApps" class="scroll-target style-scope patent-result">
              Priority Applications (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002215239A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002215239A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2000-11-06</span>
                    <span class="td nowrap style-scope patent-result">2001-11-06</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        Screening methods based on transcriptional regulation analysis system using transformed cell lines 
     <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        KR2000/65656<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2000-11-06</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20020035393A/en"><a id="link" href="#" class="style-scope state-modifier">KR1020000065656A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2000-11-06</span>
                    <span class="td style-scope patent-result">Reporter Vectors for Evaluating the Activity of Transcription Factors or Promoters and Cell Lines Transformed with the same 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2002-09-06</span>
                    <span class="td nowrap style-scope patent-result">DFPE</span>
                    <span class="td nowrap style-scope patent-result">Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2002-10-30</span>
                    <span class="td nowrap style-scope patent-result">121</span>
                    <span class="td nowrap style-scope patent-result">Ep: the epo has been informed by wipo that ep was designated in this application</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2002-11-07</span>
                    <span class="td nowrap style-scope patent-result">AK</span>
                    <span class="td nowrap style-scope patent-result">Designated states</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Kind code of ref document</strong>: A3</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Designated state(s)</strong>: AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2002-11-07</span>
                    <span class="td nowrap style-scope patent-result">AL</span>
                    <span class="td nowrap style-scope patent-result">Designated countries for regional patents</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Kind code of ref document</strong>: A3</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Designated state(s)</strong>: GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2003-05-06</span>
                    <span class="td nowrap style-scope patent-result">WWE</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: entry into national phase</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 1020037006230</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: KR</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 1020037006229</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: KR</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2003-07-22</span>
                    <span class="td nowrap style-scope patent-result">WWR</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: refused in national office</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 1020037006229</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: KR</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2003-07-22</span>
                    <span class="td nowrap style-scope patent-result">WWW</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: withdrawn in national office</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 1020037006229</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: KR</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2003-08-06</span>
                    <span class="td nowrap style-scope patent-result">WWP</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: published in national office</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 1020037006230</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: KR</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2003-09-18</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: DE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: 8642</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2004-01-02</span>
                    <span class="td nowrap style-scope patent-result">122</span>
                    <span class="td nowrap style-scope patent-result">Ep: pct application non-entry in european phase</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2006-01-17</span>
                    <span class="td nowrap style-scope patent-result">NENP</span>
                    <span class="td nowrap style-scope patent-result">Non-entry into the national phase</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: JP</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2006-01-17</span>
                    <span class="td nowrap style-scope patent-result">WWW</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: withdrawn in national office</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: JP</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2006-02-07</span>
                    <span class="td nowrap style-scope patent-result">WWR</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: refused in national office</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 1020037006230</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: KR</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1780000131" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1780000131" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=622319203" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>